A 36-year-old woman complains of difficulty falling asleep over the past 4 months. On detailed history taking, she says that she drinks her last cup of tea at 8:30 p.m. before retiring at 10:30 p.m. She then watches the time on her cell phone on and off for an hour before falling asleep. In the morning, she is tired and makes mistakes at work. Her husband has not noticed excessive snoring or abnormal breathing during sleep. Medical history is unremarkable. She has smoked 5–7 cigarettes daily for 7 years and denies excess alcohol consumption. Her physical examination is normal. Which of the following is the best initial step in the management of this patient’s condition?
An 11-year-old girl is brought to her primary care physician by her mother with complaints of constant lower abdominal pain and foul-smelling urine for the past 2 days. The patient has had several previous episodes of simple urinary tract infections in the past. Her vitals signs show mild tachycardia without fever. Physical examination reveals suprapubic tenderness without costovertebral angle tenderness on percussion. Urinalysis reveals positive leukocyte esterase and nitrite. Further questioning reveals that the patient does not use the school toilets and holds her urine all day until she gets home. When pressed further, she gets teary-eyed and starts to cry and complains that other girls will make fun of her if she uses the bathroom and will spread rumors to the teachers and her friends. She reports that though this has never happened in the past it concerns her a great deal. Which of the following is the most likely diagnosis for this patient?
A 19-year-old male college student is admitted to an inpatient psychiatric unit with a chief complaint of “thoughts about killing my girlfriend.” The patient explains that throughout the day he becomes suddenly overwhelmed by thoughts about strangling his girlfriend and hears a voice saying “kill her.” He recognizes the voice as his own, though it is very distressing to him. After having such thoughts, he feels anxious and guilty and feels compelled to tell his girlfriend about them in detail, which temporarily relieves his anxiety. He also worries about his girlfriend dying in various ways but believes that he can prevent all of this from happening and “keep her safe” by repeating prayers out loud several times in a row. The patient has no personal history of violence but has a family history of psychotic disorders. He has been on haloperidol and fluoxetine for his symptoms in the past but neither was helpful. In addition to psychotherapy, which of the following medications is the most appropriate treatment for this patient?
A 32-year-old woman comes in to see her physician because she has had undiagnosed abdominal pain for the past 3 and a half years. Her pain is not related to meals and does not correspond to a particular time of day, although she does report nausea and bloating. In the past two years she has had two endoscopies, a colonoscopy, and an exploratory laparoscopy - without any results. She is very concerned because her mother has a history of colon cancer. The patient has been unable to work or maintain a social life because she's constantly worrying about her condition. What is this patient's most likely diagnosis?
A 35-year-old woman presents to the emergency room with chest pain. She describes the chest pain as severe, 9/10, sharp in character, and diffusely localized to anterior chest wall. She also says she is sweating profusely and feels like “she is about to die”. She has presented to at least 4 different emergency rooms over the past month with similar episodes which resolve after 10–15 minutes with no sequelae or evidence of cardiac pathology. However, she says she is fearful every day of another episode. No significant past medical history. Vital signs are within normal limits, and physical examination is unremarkable. Laboratory findings, including cardiac troponins, are normal. Which of the following is the best pharmacological treatment for long-term management of this patient?
A 25-year-old female is brought to the physician by her mother who is concerned about her recent behaviors. The mother states that her daughter has been collecting “useless items” in her apartment over the last year. When she tried to persuade her daughter to throw away several years’ worth of old newspapers, her daughter had an angry outburst and refused to speak to her for two weeks. The patient reluctantly admits that she keeps “most things just in case they become useful later on.” She also states that she has felt less interested in seeing friends because she does not want them to come over to her apartment. She has also not been sleeping well, as her bed has become an additional storage space and she must sleep on her futon instead. The patient states that she is sometimes bothered by the messiness of her apartment, but otherwise doesn't think anything is wrong with her behavior. Physical exam is unremarkable. Which of the following is the best next step in management?
A 52-year-old man visits his primary care provider for a routine check-up. He reports he has always had trouble sleeping, but falling asleep and staying asleep have become more difficult over the past few months. He experiences daytime fatigue and sleepiness but does not have time to nap. He drinks one cup of coffee in the morning and drinks 3 alcoholic beverages nightly. His medical history is positive for essential hypertension for which he takes lisinopril. Vital signs include a temperature of 36.9°C (98.4°F), blood pressure of 132/83 mm Hg, and heart rate of 82/min. Physical examination is unremarkable. Which of the following best describes the effect of alcohol use at night on the sleep cycle?
A 26-year-old man presents to the behavioral health clinic for assistance overcoming his fear of public speaking. He has always hated public speaking. Two weeks ago, he was supposed to present a research project at school but had to leave the podium before the presentation. He recalled that his heart was racing, his palms were sweating, and that he could not breathe. These symptoms resolved on their own after several minutes, but he felt too embarrassed to return to college the next day. This had also happened in high school where, before a presentation, he started sweating and felt palpitations and nausea that also resolved on their own. He is scheduled for another presentation next month and is terrified. He states that this only happens in front of large groups and that he has no problems communicating at small gatherings. Other than his fear of public speaking, he has a normal social life and many friends. He enjoys his classes and a part-time job. Which of the following is the most likely diagnosis?
A 7-year-old girl is brought to the physician by her mother because she has been increasingly reluctant to speak at school over the past 4 months. Her teachers complain that she does not answer their questions and it is affecting her academic performance. She was born at 35 weeks' gestation and pregnancy was complicated by preeclampsia. Previous well-child examinations have been normal. Her older brother was diagnosed with a learning disability 4 years ago. She is at 65th percentile for height and weight. Physical examination shows no abnormalities. She follows commands. She avoids answering questions directly and whispers her answers to her mother instead who then mediates between the doctor and her daughter. Which of the following is the most likely diagnosis?
A previously healthy 30-year-old woman comes to the physician because of nervousness and difficulty sleeping over the past 4 weeks. She has difficulty falling asleep at night because she cannot stop worrying about her relationship and her future. Three months ago, her new boyfriend moved in with her. Before this relationship, she had been single for 13 years. She reports that her boyfriend does not keep things in order in the way she was used to. Sometimes, he puts his dirty dishes in the kitchen sink instead of putting them in the dishwasher directly. He refuses to add any groceries to the shopping list when they are used up. He has also suggested several times that they have dinner at a restaurant instead of eating at home, which enrages her because she likes to plan each dinner of the week and buy the required groceries beforehand. The patient says that she really loves her boyfriend but that she will never be able to tolerate his “flaws.” Vital signs are within normal limits. Physical examination shows no abnormalities. On mental status examination, she is cooperative but appears distressed. Her affect has little intensity or range. Which of the following is the most likely diagnosis?
Explanation: ***Proper sleep hygiene*** - The patient's history of difficulty falling asleep, using a cell phone before bed, and tea consumption close to bedtime points towards **poor sleep hygiene** as a primary contributor to her insomnia. - Addressing these behavioral factors first with **sleep hygiene education** is the most appropriate initial step before considering pharmacologic interventions. *Ropinirole* - **Ropinirole** is a dopamine agonist primarily used to treat **Parkinson's disease** and **restless legs syndrome**. - There are no indications in the patient's presentation, such as an irresistible urge to move the legs, that would suggest restless legs syndrome. *Continuous positive airway pressure* - **Continuous positive airway pressure (CPAP)** is the standard treatment for **obstructive sleep apnea (OSA)**. - The patient's husband has not noticed snoring or abnormal breathing during sleep, making OSA less likely as the primary cause of her insomnia. *Modafinil* - **Modafinil** is a wakefulness-promoting agent used to treat **narcolepsy** and other disorders characterized by excessive daytime sleepiness. - The patient's primary complaint is difficulty *falling asleep* (**insomnia**), not excessive daytime sleepiness, and there's no evidence of narcolepsy. *Paroxetine* - **Paroxetine** is a selective serotonin reuptake inhibitor (SSRI) used to treat **depression** and **anxiety disorders**, and sometimes insomnia associated with these conditions. - There is no mention of symptoms of depression or anxiety in the patient's history that would warrant immediate antidepressant use for her sleep difficulties.
Explanation: ***Social anxiety disorder*** - The girl's fear of being judged and talked about for using the school bathroom, despite no prior negative experiences, is a hallmark of **social anxiety disorder**. This anxiety leads to her avoiding a social situation (using public restrooms) and has functional impairment (recurrent UTIs). - This condition involves significant anxiety about social situations where the individual might be scrutinized or negatively evaluated by others, often leading to avoidance and distress. *Social anxiety disorder, performance only* - **Social anxiety disorder, performance only** is characterized by anxiety only in speaking or performing in public. - The patient's fear extends beyond performance situations to general social judgment related to using a public restroom. *Agoraphobia* - **Agoraphobia** involves fear of situations from which escape might be difficult or embarrassing, leading to avoidance of public transportation, open spaces, enclosed places, standing in line, or being outside the home alone. - The patient's anxiety is specifically linked to social evaluation in a public restroom, not difficulty with escape or perceived helplessness in public spaces generally. *Panic disorder* - **Panic disorder** is characterized by recurrent, unexpected panic attacks, which are marked by intense fear and physical symptoms like palpitations, sweating, and shortness of breath. - While the patient experiences anxiety, it is situation-specific (social evaluation) rather than unexpected panic attacks, and she describes crying, not a full-blown panic attack. *Specific phobia* - A **specific phobia** is an intense, irrational fear of a particular object or situation (e.g., spiders, heights, flying). - The patient's fear is not of the bathroom itself, but of the **social judgment** and negative evaluation from peers if she uses it, which points to a social rather than a specific phobia.
Explanation: ***Clomipramine*** - This patient presents with **obsessive thoughts** (about killing his girlfriend, preventing her death) and **compulsive behaviors** (repetition of prayers, confessing thoughts to relieve anxiety). These symptoms are highly suggestive of **Obsessive-Compulsive Disorder (OCD)**. - **Clomipramine** is a **tricyclic antidepressant (TCA)** with potent serotonin reuptake inhibition and is considered the **most effective medication for OCD**, particularly when SSRIs (like fluoxetine, which this patient already failed) are ineffective. - The patient's previous trial of **fluoxetine (an SSRI) was unsuccessful**, making clomipramine the most appropriate next-line agent for OCD. *Alprazolam* - **Alprazolam** is a **benzodiazepine** primarily used for **acute anxiety relief** and panic disorder. - It is not indicated as a primary treatment for OCD, and its use could lead to dependence without addressing the underlying obsessive-compulsive symptoms. *Quetiapine* - **Quetiapine** is an **atypical antipsychotic** effective in treating psychotic disorders (e.g., schizophrenia, bipolar disorder) and as an augmentation for depression. - While the patient has a family history of psychotic disorders and experiences distressing internal voices, his symptoms are better explained by **OCD with ego-dystonic intrusive thoughts** rather than a primary psychotic disorder. The voice is recognized as his own thoughts, and he has clear compulsive behaviors with anxiety relief from rituals—features characteristic of OCD, not psychosis. - The failure of **haloperidol** (antipsychotic) further supports that this is OCD, not a psychotic disorder. *Amitriptyline* - **Amitriptyline** is a **tricyclic antidepressant (TCA)** mainly used for depression, neuropathic pain, and insomnia. - While it has some serotonin reuptake inhibition, it is **not as potent or as specifically indicated for OCD as clomipramine**. *Buspirone* - **Buspirone** is an **anxiolytic** used for generalized anxiety disorder. - It works on serotonin receptors but is not effective for the treatment of OCD.
Explanation: ***Somatic symptom disorder*** - This condition involves **physical symptoms** without an identifiable medical cause, accompanied by **excessive thoughts, feelings, or behaviors related to the symptoms**. The patient's persistent abdominal pain, nausea, and bloating, despite extensive negative diagnostic workups, align with this. - The patient's significant **distress and functional impairment** (unable to work or maintain a social life), coupled with constant worry about her condition, are key features. *Functional neurologic symptom disorder* - Characterized by **neurological symptoms** (e.g., paralysis, blindness, seizures) that are inconsistent with neurological disease. - The patient's symptoms are primarily gastrointestinal and pain-related, not neurological. *Hypochondriasis* - This term is largely replaced by **illness anxiety disorder** in DSM-5, characterized by a preoccupation with having or acquiring a serious illness despite minimal or no somatic symptoms. - The patient in the vignette has actual physical symptoms (abdominal pain, nausea, bloating), which differentiates it from typical illness anxiety disorder. *Body dysmorphic disorder* - Involves a preoccupation with an imagined or slight defect in **physical appearance**. - The patient's concerns are focused on an internal physical illness, not her appearance. *Factitious disorder* - Characterized by the **intentional production or feigning of physical or psychological symptoms** for the purpose of assuming the sick role. - There is no evidence in the vignette to suggest the patient is intentionally fabricating her symptoms; her distress appears genuine.
Explanation: ***Paroxetine*** - This patient presents with symptoms highly suggestive of **panic disorder**, characterized by recurrent, unexpected panic attacks and persistent worry about future attacks. **SSRIs like paroxetine** are considered first-line pharmacological treatment for long-term management of panic disorder. - **Paroxetine** helps reduce the frequency and severity of panic attacks by modulating **serotonin levels** in the brain, and its efficacy is well-established for long-term symptom control. *Nortriptyline* - Nortriptyline is a **tricyclic antidepressant (TCA)**. While TCAs can be effective for panic disorder, they are generally considered second-line due to a less favorable side-effect profile (e.g., anticholinergic effects, cardiac toxicity in overdose) compared to SSRIs. - Its use is often limited to cases where SSRIs are ineffective or contraindicated, making it not the best first-line choice for long-term management. *Phenelzine* - Phenelzine is a **monoamine oxidase inhibitor (MAOI)**. MAOIs are highly effective in treating panic disorder but are typically reserved for **refractory cases** due to significant drug-drug and food-drug interactions (e.g., tyramine crisis, serotonin syndrome) that necessitate strict dietary restrictions. - Given its complex safety profile, it is not considered a first-line agent, especially when safer and equally effective options like SSRIs are available. *Clomipramine* - Clomipramine is another **TCA** with a potent effect on serotonin reuptake. It is effective for panic disorder, but similar to nortriptyline, its use is often limited by its **side-effect profile (e.g., anticholinergic effects, sedation, cardiac risks)**. - While it can be used, particularly in cases of **co-morbid obsessive-compulsive disorder (OCD)**, SSRIs are generally preferred as first-line due to better tolerability for long-term use in panic disorder. *Benzodiazepine* - Benzodiazepines (e.g., lorazepam, alprazolam) are highly effective for the **acute management of panic attacks** due to their rapid onset of action in reducing anxiety symptoms. - However, they are **not recommended for long-term management** due to the risks of **dependence, tolerance, withdrawal symptoms**, and potential for abuse. Long-term treatment for panic disorder focuses on preventing attacks, for which SSRIs are superior.
Explanation: ***Cognitive behavioral therapy for hoarding disorder*** - **Cognitive behavioral therapy (CBT)**, specifically tailored for hoarding disorder, is considered the **first-line and most effective treatment**. It focuses on addressing the **cognitive distortions** related to saving items and the behavioral patterns of acquiring and not discarding. - CBT helps patients develop skills to organize, categorize, and discard items, and to cope with the emotional distress associated with decluttering, which is crucial for long-term management. *High dose SSRI for hoarding disorder* - While **SSRIs (Selective Serotonin Reuptake Inhibitors)** can be helpful for comorbid anxiety or depression often present in hoarding disorder, they are generally considered **second-line treatments** for **hoarding disorder itself**, especially when compared to CBT. - High doses of SSRIs are sometimes used, but the initial approach usually involves a combination with or precedes pharmacological intervention. *Tricyclic antidepressant for hoarding disorder* - **Tricyclic antidepressants (TCAs)** are generally not the first-line pharmacological treatment for hoarding disorder, as **SSRIs are preferred** if medication is deemed necessary. - TCAs have a **less favorable side effect profile** compared to SSRIs and are typically reserved for cases where SSRIs are ineffective or contraindicated. *Intervention by patient’s mother to declutter the home* - While well-intentioned, a direct intervention by the mother to declutter the home without the patient's agreement or participation can be **counterproductive**. - This approach can lead to **significant distress** for the patient, damage family relationships, and does not address the underlying cognitive and behavioral issues contributing to the hoarding. *Admission to psychiatric facility* - **Admission to a psychiatric facility** is typically reserved for individuals who are an **imminent danger to themselves or others**, or who are unable to care for themselves due to severe mental illness. - While the patient's living situation is messy and impacting her social life and sleep, there is no indication of **acute danger or severe functional impairment** warranting inpatient psychiatric care at this time.
Explanation: ***Inhibits REM*** - **Alcohol** is a central nervous system depressant that initially induces sleep but significantly **disrupts sleep architecture**, especially **REM sleep**, leading to non-restorative sleep. - The suppression of **REM sleep** by alcohol can contribute to the patient's reported daytime fatigue, despite seemingly getting enough sleep. *Increases total REM sleep* - This is incorrect; alcohol consumption, particularly chronic or heavy use, is known to **decrease the total amount of REM sleep**. - While there might be a brief increase in non-REM sleep at the beginning of the night, the overall effect on REM is inhibitory. *Inhibits stage N1* - This is incorrect; alcohol typically **shortens sleep latency** (the time it takes to fall asleep) and thus can actually **increase the duration of stage N1** (light sleep) initially or lead to more awakenings back into N1. - **Alcohol's sedative effects** aid in falling asleep faster, but this is often followed by fragmented sleep. *REM (rapid eye movement) rebound* - Though **REM rebound** can occur during withdrawal after chronic alcohol use, it is not the direct effect of alcohol consumption itself on the sleep cycle. - **REM rebound** is a compensatory phenomenon where the body tries to make up for lost REM sleep, often leading to vivid dreams and nightmares during withdrawal. *Increases stage N1* - While alcohol can cause a quicker transition into sleep, it often leads to a **fragmented sleep architecture**, potentially increasing the amount of time spent in lighter sleep stages like N1 due to frequent awakenings and difficulty maintaining deeper sleep. - However, the most significant and detrimental effect on sleep quality is its **inhibition of REM sleep**.
Explanation: ***Social anxiety disorder, performance only*** - The patient exhibits marked fear and anxiety specifically in **social situations involving performance** (public speaking), while having no issues with general social interactions. - His physical symptoms (**racing heart, sweating, difficulty breathing**) are consistent with anxiety, and his avoidance and distress meet the criteria for social anxiety disorder, but limited to performance situations. *Social anxiety disorder, generalized* - This diagnosis would imply fear and anxiety in **a broad range of social situations**, not just performance-related ones. - The patient explicitly states he has no problems communicating at small gatherings and has a normal social life, ruling out a generalized presentation. *Normal human behavior* - While some degree of nervousness before public speaking is common, the patient's symptoms are of **panic-level intensity** (e.g., leaving the podium, inability to breathe) and cause significant distress and functional impairment. - These severe, recurrent reactions go beyond normal apprehension and indicate a diagnosable condition. *Panic disorder* - **Panic disorder** is characterized by recurrent, unexpected panic attacks that are not tied to a specific trigger or situation. - The patient's attacks are consistently triggered by **public speaking** rather than being unexpected, which points away from panic disorder. *Panic disorder with agoraphobia* - This diagnosis involves panic attacks coupled with **agoraphobia**, which is fear or avoidance of situations where escape might be difficult or help unavailable during a panic attack (e.g., crowds, open spaces, public transportation). - The patient's symptoms are clearly linked to public speaking occasions and do not involve broader situational avoidance as seen in agoraphobia.
Explanation: ***Selective mutism*** - The child's reluctance to speak in specific social situations (school) despite being able to speak in others (whispering to her mother), and the impact on academic performance, are classic signs of **selective mutism** - **Selective mutism** typically involves anxiety and a consistent failure to speak in situations where speaking is expected, despite speaking in other situations - This diagnosis fits the **DSM-5 criteria**: consistent failure to speak in specific social situations for >1 month, interfering with educational achievement *Social anxiety disorder* - While social anxiety can be **comorbid** with selective mutism, the hallmark of this presentation is the **specific refusal to speak** in certain settings, rather than generalized anxiety about social interactions - A child with generalized social anxiety might interact nervously but would likely attempt to speak, which is not described here *Rett syndrome* - **Rett syndrome** is a neurodevelopmental disorder almost exclusively affecting girls, characterized by **normal early development followed by regression** of acquired skills, loss of purposeful hand use, and deceleration of head growth - The presented symptoms of reluctance to speak in specific settings, without other regressive signs or developmental abnormalities, do not fit the diagnosis of Rett syndrome *Autism spectrum disorder* - **Autism spectrum disorder** is characterized by persistent deficits in **social communication and social interaction** across multiple contexts, and **restricted, repetitive patterns of behavior** - This child's ability to speak to her mother and follow commands suggests intact communication skills in some contexts, making autism less likely than selective mutism for the primary presentation *Reactive attachment disorder* - **Reactive attachment disorder** typically arises from patterns of **extremely insufficient care** in early childhood, leading to emotionally withdrawn behavior toward caregivers and limited positive affect - The child's selective non-speaking in school in this scenario, with normal previous well-child examinations and interaction with her mother, is inconsistent with the characteristic features of reactive attachment disorder
Explanation: ***Obsessive-compulsive personality disorder*** - This patient displays pervasive patterns of **perfectionism, orderliness, and control**, along with an **inflexibility** that causes significant distress in her relationship. - Her inability to tolerate deviations from her routines and expectations, even in minor domestic matters, is characteristic of OCPD. - Importantly, her behaviors are **ego-syntonic** (she views her need for order as reasonable and blames her boyfriend's "flaws"), which is typical of personality disorders. *Major depressive disorder* - While she experiences nervousness and difficulty sleeping, these symptoms are attributed to worrying about her relationship rather than the pervasive low mood, anhedonia, and other vegetative symptoms typical of **major depressive disorder**. - Her distress is specifically tied to her need for control and order, which is not the primary feature of depression. *Generalized anxiety disorder* - This diagnosis involves **excessive, uncontrollable worry** about multiple events or activities for at least 6 months, often accompanied by restlessness, fatigue, and muscle tension. - While she has anxiety, it stems from rigid adherence to rules and routines, which points more specifically to a personality disorder rather than generalized anxiety. - Duration is also only 4 weeks, not meeting the 6-month criterion for GAD. *Obsessive-compulsive disorder* - OCD is characterized by **recurrent, intrusive thoughts (obsessions)** and **repetitive behaviors or mental acts (compulsions)** that the individual feels driven to perform in response to an obsession. - This patient does not report specific obsessions or compulsions; her behaviors are **ego-syntonic** (consistent with her values) rather than **ego-dystonic** (recognized as unreasonable), which would be seen in OCD. *Schizoid personality disorder* - Patients with schizoid personality disorder typically exhibit a pervasive pattern of **detachment from social relationships** and a restricted range of emotional expression. - This patient is in a relationship and expresses distress about its challenges, indicating a desire for connection rather than detachment.
Explanation: ***Memory loss is usually self-limiting.*** * This patient is exhibiting symptoms consistent with **dissociative amnesia**, characterized by an inability to recall important personal information, usually of a traumatic or stressful nature, that is too extensive to be explained by ordinary forgetfulness. * Dissociative amnesia, particularly **localized amnesia** (inability to recall specific events during a circumscribed period), often has a **spontaneous and complete recovery** of memory. *Patients are more likely to also have bipolar disorder.* * While comorbidity is common in psychiatric disorders, **dissociative disorders** are more frequently comorbid with conditions like **post-traumatic stress disorder (PTSD)**, **depression**, **anxiety disorders**, and **personality disorders**, rather than bipolar disorder specifically. * There is no strong statistical link suggesting a higher likelihood of co-occurring **bipolar disorder** in patients with dissociative amnesia. *The condition is the least common form of dissociative disorder.* * **Dissociative amnesia** is actually considered one of the **more common** forms of dissociative disorders, particularly given its association with trauma. * **Dissociative identity disorder (DID)** is generally considered the *least* common, but also the most severe. *Patients are unable to recall only minor or obscure details in this condition.* * In dissociative amnesia, the memory loss typically involves **significant autobiographical information** and **major traumatic events**, not just minor or obscure details. * The patient's inability to recall "many of the details of the accident" represents **substantial memory loss** of a significant traumatic event, which is characteristic of dissociative amnesia. *Pharmacotherapy is the mainstay of treatment.* * **Psychotherapy**, particularly trauma-focused therapy, is considered the **mainstay of treatment** for dissociative amnesia. * Medications may be used to treat **comorbid conditions** like depression or anxiety, but they do not directly treat the dissociative symptoms or memory loss itself.
Explanation: ***Generalized anxiety disorder*** - The patient exhibits persistent and excessive worry about various life circumstances (performance, burglaries, general anxiety), accompanied by physical symptoms like **restlessness**, muscle tension, and sleep disturbances, which are hallmark features of **Generalized Anxiety Disorder (GAD)**. - The symptoms have been present for **8 months**, exceed the diagnostic duration for GAD (at least 6 months), and are not clearly tied to a specific stressor or episodic panic attacks. *Atypical depressive disorder* - Atypical depression is characterized by mood reactivity, increased appetite/weight gain, hypersomnia, leaden paralysis, and interpersonal rejection sensitivity. - This patient reports difficulty sleeping (*insomnia*) and primarily presents with anxiety symptoms, not depressive mood. *Adjustment disorder* - **Adjustment disorder** involves emotional or behavioral symptoms in response to an identifiable stressor, occurring within 3 months of the stressor's onset, and usually resolving within 6 months after the stressor or its consequences have ceased. - The patient's symptoms are chronic (8 months), excessive, and not solely linked to *one* identifiable recent stressor, but rather a pervasive pattern of worry. *Panic disorder* - **Panic disorder** is characterized by recurrent unexpected **panic attacks** with sudden onset of intense fear and physical symptoms (e.g., palpitations, dyspnea, dizziness). - While she experiences sudden restlessness and nausea related to performances, these are specific triggers and not unexpected, unprovoked panic attacks. The primary pattern is persistent worry, not recurrent panic attacks. *Essential tremor* - **Essential tremor** is a neurological condition causing an *action tremor*, often visible when performing daily tasks, and typically improves with alcohol. - While she has a tremor that improves with alcohol, the presence of marked and pervasive psychological symptoms like severe worrying, restlessness, and insomnia point to an underlying anxiety disorder, not solely an isolated neurological tremor.
Explanation: ***Excessive impulsivity and inattention*** - The patient exhibits features of **Tourette syndrome**, characterized by multiple motor **tics** and at least one vocal tic present for longer than a year, with onset before age 18. - Tourette syndrome is frequently comorbid with **attention-deficit/hyperactivity disorder (ADHD)**, which presents with symptoms of **inattention** and **hyperactivity-impulsivity**. *Feelings of persistent sadness and loss of interest* - These symptoms describe **major depressive disorder**, which is less commonly comorbid with Tourette syndrome in childhood and less directly linked than ADHD. - While depression can occur, the primary associations with Tourette's during childhood are more behavioral and attention-related. *Defiant and hostile behavior toward teachers and parents* - This symptom profile suggests **oppositional defiant disorder (ODD)** or **conduct disorder**, which are less common comorbidities of Tourette syndrome than ADHD. - While behavioral issues can arise from the distress of tics, ODD is not the most direct or prevalent comorbidity. *Recurrent episodes of intense fear* - This symptom describes **panic attacks** or an **anxiety disorder**, which can co-occur with Tourette syndrome, but less frequently than ADHD. - The primary clinical picture presented (tics and academic decline) points more strongly to an attention-related comorbidity. *Chorea and hyperreflexia* - **Chorea** and **hyperreflexia** are neurological signs not typically associated with Tourette syndrome; they are more characteristic of conditions like Huntington's disease or Sydenham chorea. - Tourette syndrome is a **neurological disorder** of tics, not a progressive degenerative disorder with chorea and hyperreflexia.
Explanation: ***Patients generally have insight into their condition.*** - Patients with **Obsessive-Compulsive Disorder (OCD)** typically recognize that their obsessions and compulsions are **irrational or excessive**, but they feel unable to resist them. - This **insight** is a defining characteristic, differentiating OCD from psychotic disorders where insight is often lacking. *There is no role for deep brain stimulation.* - **Deep Brain Stimulation (DBS)** is an approved treatment for **severe, refractory OCD** that has not responded to conventional pharmacological and behavioral therapies. - While not first-line, it is a viable option for a small subset of patients. *Compulsions are logically related to the obsessions.* - While compulsions are an attempt to reduce distress from obsessions, they are often **not logically or realistically connected** to the obsession. - For example, repetitive handwashing does not realistically prevent all contamination in the way the patient believes. *Disturbing thoughts are usually ego-syntonic.* - The disturbing thoughts (obsessions) in OCD are typically **ego-dystonic**, meaning they are **contrary to the patient's conscious desires and values**, causing significant distress. - Ego-syntonic thoughts are consistent with one's self-perception and, therefore, usually do not cause distress. *Behavioral treatment is not as effective as drug therapy.* - **Exposure and Response Prevention (ERP)**, a form of cognitive-behavioral therapy, is considered the **most effective behavioral treatment** for OCD and often yields better long-term results than medication alone. - A combination of ERP and **pharmacotherapy (SSRIs)** is often the most effective approach.
Explanation: ***Stimulus control therapy*** - This therapy focuses on **removing cues** that hinder sleep and **establishing a strong association** between the bed/bedroom and sleep. - The recommendations (leaving the bedroom when awake, returning only when sleepy, avoiding daytime naps) are classic components of **stimulus control therapy** for insomnia. *Cognitive behavioral therapy* - **CBT-I** is a comprehensive approach that includes stimulus control, sleep hygiene, relaxation techniques, and cognitive restructuring. - While stimulus control is a part of CBT-I, the recommendations provided are specifically designed to address conditioning and are thus best classified as stimulus control therapy. *Relaxation* - Relaxation techniques involve methods like **progressive muscle relaxation**, **deep breathing exercises**, or **meditation** to reduce physiological arousal. - The given recommendations do not directly involve these types of activities but rather focus on changing behaviors around sleep. *Improved sleep hygiene* - Sleep hygiene involves practices that promote good sleep, such as maintaining a **regular sleep schedule**, ensuring a **comfortable sleep environment**, and **avoiding caffeine/alcohol** before bed. - While avoiding daytime naps is related to sleep hygiene, the core recommendations (leaving the bedroom when awake, returning only when sleepy) specifically target conditional associations with the bed, making them more characteristic of stimulus control. *Sleep restriction* - Sleep restriction therapy involves **limiting the time spent in bed** to the actual time asleep, with the goal of building up sleep drive and improving sleep efficiency. - The recommendations given do not specify a fixed reduction in time allowed in bed but rather focus on behavioral responses to wakefulness in bed.
Explanation: ***Fluoxetine*** - The patient exhibits symptoms consistent with **generalized anxiety disorder** (GAD), including excessive worry about multiple areas of life (health, job, relationships, sexual performance) for over a year, and associated physical symptoms (headaches). **SSRIs like fluoxetine** are first-line treatment for GAD. - The patient's multiple health concerns, despite a normal neurological exam, and his persistent worries suggest an underlying anxiety disorder that would benefit from pharmacological intervention. *Buspirone* - Buspirone is an **anxiolytic** that can be used for GAD, but it typically has a **slower onset of action** and is often considered a second-line agent or an add-on therapy rather than the initial monotherapy for severe, pervasive anxiety. - While it may be suitable, an **SSRI (like fluoxetine)** is generally preferred as the first-line and most effective option for chronic GAD due to its broader efficacy profile. *Sumatriptan* - **Sumatriptan is a triptan** used for the acute treatment of **migraines** and cluster headaches. - The patient's headaches are recurrent but he denies having one currently, and the primary concern appears to be underlying anxiety rather than the acute management of a headache. *Clonazepam* - Clonazepam is a **benzodiazepine**, which can provide rapid relief for anxiety symptoms. However, it is typically used for **short-term management** of acute anxiety or as an adjunct due to its potential for **dependence** and withdrawal symptoms. - It is not recommended as a first-line, long-term monotherapy for chronic GAD, as it does not address the underlying anxious thought patterns as effectively as SSRIs. *MRI head* - This patient has a normal neurological exam, making a **diagnostic MRI head** for headaches in the absence of **focal neurological deficits** or "red flag" symptoms (e.g., papilledema, thunderclap headache) unnecessary as an initial step. - While the patient is concerned about cancer, further imaging is not indicated given the current clinical presentation strongly suggesting an **anxiety disorder**.
Explanation: ***Administer intravenous lorazepam*** - The patient's symptoms (agitation, restlessness, tremors, sweating, tachycardia, hypertension, and anxiety) occurring post-surgery in a patient with a history of heavy alcohol use are highly suggestive of alcohol withdrawal syndrome. - Benzodiazepines like lorazepam are the first-line treatment for alcohol withdrawal due to their sedative, anxiolytic, and anticonvulsant properties, which can prevent progression to more severe complications like seizures or delirium tremens. *Administer 5% dextrose in 1/2 normal saline* - This solution is primarily used to address dehydration and provide some caloric support, but it does not directly manage the neuroexcitatory symptoms of alcohol withdrawal. - While supportive care including fluids is important, addressing the underlying alcohol withdrawal is the immediate priority. *Administer intravenous naloxone* - Naloxone is an opioid antagonist used to reverse opioid overdose. - The patient's symptoms are inconsistent with opioid overdose; in fact, he is experiencing agitation and autonomic hyperactivity, which are the opposite of opioid effects. *Administer intravenous propranolol* - Propranolol is a beta-blocker that can help control some autonomic symptoms like tachycardia and hypertension, but it does not address the underlying neuroexcitability or prevent seizures associated with alcohol withdrawal. - It should not be used as monotherapy for alcohol withdrawal and should be given cautiously, often after benzodiazepines, especially in patients with respiratory concerns. *Administer intravenous dexamethasone* - Dexamethasone is a potent corticosteroid used for anti-inflammatory or immunosuppressive effects and in conditions like cerebral edema or adrenal insufficiency. - It has no role in the management of alcohol withdrawal syndrome.
Explanation: ***Generalized anxiety disorder*** - The patient describes **severe pain upon attempted penetration** and significant distress about her inability to have intercourse, consistent with **genito-pelvic pain/penetration disorder (GPPPD)**, formerly known as dyspareunia, vaginismus, and sexual aversion disorder. - While GPPPD is multi-factorial, **anxiety and psychological distress** are significant risk factors and often exacerbate the condition, leading to muscle guarding and increased pain perception. *Low estrogen state* - This patient is a pre-menopausal 21-year-old with a normal BMI, making a **low estrogen state** highly unlikely. - Low estrogen typically leads to **vulvovaginal atrophy**, dryness, and pain, which would present with objective findings like vulvar skin changes or atrophy, not observed in this case. *Endometriosis* - Endometriosis causes **deep dyspareunia** (pain with deep penetration), often accompanied by chronic pelvic pain, dysmenorrhea, and infertility. - The patient's pain is described as severe with *attempted penetration at the introitus*, which is more superficial than typical endometriosis-related pain. *Squamous cell carcinoma of the vulva* - This condition is typically found in older women and associated with a history of **HPV infection** or chronic inflammation. - It would present with **visible vulvar lesions**, itching, bleeding, or palpable masses, none of which are described in the patient's exam. *Body dysmorphic disorder* - Body dysmorphic disorder involves a **preoccupation with perceived flaws** in physical appearance, leading to significant distress or impairment. - While it can impact sexual intimacy, the primary symptom described is **physical pain during attempted intercourse**, not distress over her genital appearance.
Explanation: ***Conversion disorder*** - This patient presents with **neurological symptoms (left arm paralysis)** that are **inconsistent with anatomical pathways** or known neurological diseases (unremarkable MRI), occurring after a significant psychosocial stressor (ectopic pregnancy, family conflict). - Her emotional distress, "worst family in the world" comment, and the specific symptom presentation without organic cause are classic features of **conversion disorder**. *Ischemic stroke* - A stroke would typically present with **focal neurological deficits consistent with a vascular territory**, and an MRI would show evidence of **infarction**. - The **normal MRI findings** and the specific context of psychological distress make ischemic stroke very unlikely. *Malingering* - **Malingering** involves the intentional production of false or exaggerated symptoms for obvious external incentives, such as avoiding work or obtaining financial compensation. - In this case, there is **no clear external incentive** for the patient to feign paralysis; her distress seems genuine. *Borderline personality disorder* - **Borderline personality disorder** is characterized by unstable relationships, impulsivity, identity disturbance, and chronic feelings of emptiness, often leading to self-harm or suicidal behavior. - While she has a history of anxiety and depression, and is emotionally distressed, the **sudden onset of specific neurological symptoms without an organic cause** points away from a primary diagnosis of BPD. *Factitious disorder* - **Factitious disorder** (previously Munchausen syndrome) involves deliberately faking or inducing illness in oneself for the primary purpose of assuming the "sick role" and gaining attention. - While there's no clear organic cause for her paralysis, her presentation is more aligned with an **unconscious psychological conflict converting into physical symptoms** rather than a conscious effort to deceive for secondary gain.
Explanation: ***Orthostasis*** - This patient's presentation is highly suggestive of **anorexia nervosa** (BMI 17 kg/m2, amenorrhea, excessive exercise, fear of weight gain despite emaciation, and lack of sexual desire). **Orthostasis** (a drop in blood pressure upon standing) is a common finding due to **dehydration** and **volume depletion** often present in patients with anorexia nervosa. - **Bradycardia** and **hypotension** (which contributes to orthostasis) are frequent cardiovascular complications of anorexia nervosa as the body attempts to conserve energy. *Hypocholesterolemia* - Patients with anorexia nervosa more commonly present with **hypercholesterolemia**, not hypocholesterolemia. - This paradox is thought to be due to **decreased cholesterol degradation** and **impaired metabolism** in the setting of severe caloric restriction. *Primary amenorrhea* - The patient's last menstrual period was 4 months ago, indicating she has experienced menstruation in the past. Therefore, her amenorrhea is **secondary** (cessation of menses for 3 consecutive months in a woman who has previously menstruated), not primary (absence of menses by age 15 or within 5 years of thelarche). - The **hypothalamic-pituitary-gonadal axis dysfunction** due to low body weight and nutritional deficiency leads to secondary amenorrhea in anorexia nervosa. *Hypokalemic alkalosis* - **Hypokalemic alkalosis** is typically associated with **purging behaviors** like vomiting or laxative abuse, which are characteristic of the bulimia nervosa subtype or the binge-eating/purging subtype of anorexia nervosa. - While this patient's exercise is excessive, there is no direct evidence of purging in the provided vignette; her symptoms more strongly point towards the **restrictive subtype** of anorexia nervosa, where metabolic alkalosis is less common unless purging is also occurring. *Increased LH and FSH* - In anorexia nervosa, the severe caloric restriction and low body fat lead to **hypothalamic dysfunction**, specifically affecting the release of **gonadotropin-releasing hormone (GnRH)**. - This results in **decreased production of LH and FSH** from the pituitary gland, leading to hypogonadotropic hypogonadism, which explains the amenorrhea.
Explanation: ***Fluoxetine*** - This patient's symptoms are consistent with **excoriation (skin-picking) disorder**, characterized by recurrent skin picking resulting in lesions and significant distress or impairment, often triggered by stress. - **First-line treatment** is typically **cognitive-behavioral therapy (CBT)** with habit reversal training; however, among the options provided, **selective serotonin reuptake inhibitors (SSRIs)** like fluoxetine represent the most evidence-based pharmacological approach. - **SSRIs** are considered when psychotherapy is unavailable or as adjunctive treatment for excoriation disorder and comorbid anxiety/OCD symptoms, though evidence is mixed. - Fluoxetine is the best option listed for initial management in this clinical scenario. *Dialectical behavioral therapy* - **Dialectical behavioral therapy (DBT)** is primarily used for **borderline personality disorder** and chronic suicidality, focusing on emotion regulation and distress tolerance. - While some of its techniques could be broadly helpful, it is not the primary or most effective treatment for excoriation disorder specifically. - **CBT with habit reversal training** would be preferred over DBT for this condition. *Interpersonal psychotherapy* - **Interpersonal psychotherapy (IPT)** is an evidence-based treatment mainly for **depression** and some eating disorders, focusing on improving interpersonal relationships and social functioning. - It does not directly target the compulsive behaviors or urge suppression central to excoriation disorder. *Clomipramine* - **Clomipramine**, a tricyclic antidepressant (TCA), is effective for **obsessive-compulsive disorder (OCD)**, but it has a less favorable side effect profile than SSRIs. - Due to its side effects and lower tolerability, it is usually reserved for cases resistant to SSRIs, making it not the best initial pharmacologic step. *Supportive psychotherapy* - **Supportive psychotherapy** aims to alleviate symptoms, maintain self-esteem, and improve coping skills, offering a general supportive environment. - While it can be helpful as an adjunct, it lacks the specific behavioral or pharmacological mechanisms needed for effective treatment of excoriation disorder.
Explanation: ***Cognitive behavioral therapy*** - This patient exhibits classic symptoms of **obsessive-compulsive disorder (OCD)**, characterized by intrusive thoughts (obsessions) and repetitive behaviors (compulsions) performed to alleviate anxiety. - **Exposure and response prevention (ERP)**, a component of cognitive behavioral therapy, is the first-line psychosocial treatment for OCD and has strong evidence for its efficacy in both children and adults. *Lorazepam* - **Lorazepam** is a benzodiazepine used for acute anxiety or panic attacks, providing short-term relief. - It is not a primary treatment for OCD and does not address the underlying obsessive-compulsive cycle; long-term use can lead to dependence. *Risperidone* - **Risperidone** is an atypical antipsychotic, primarily used for conditions like schizophrenia, bipolar disorder, or severe behavioral disturbances. - While sometimes used as an augmentation strategy in refractory OCD, it is not a first-line treatment, especially without prior trials of CBT or SSRIs. *Clomipramine* - **Clomipramine** is a tricyclic antidepressant (TCA) with potent serotonin reuptake inhibition, making it effective for OCD. - However, due to its less favorable side effect profile compared to selective serotonin reuptake inhibitors (SSRIs), it is typically reserved for cases where SSRIs are ineffective. *Fluoxetine* - **Fluoxetine** is an SSRI, a first-line pharmacologic treatment for OCD. - While effective, current guidelines recommend starting with **CBT (specifically ERP)** as the initial treatment for mild to moderate OCD, or combining it with medication for more severe cases.
Explanation: ***Clonazepam*** - **Clonazepam** is a **benzodiazepine** that acts rapidly to provide acute relief from severe anxiety symptoms, such as those experienced during a **panic attack**. - Its fast onset of action and anxiolytic properties make it suitable for interrupting the acute, distressing symptoms of **panic disorder**. *Imipramine* - **Imipramine** is a **tricyclic antidepressant** (TCA) and is used for long-term management of panic disorder and depression, but its onset of action is too slow for acute symptom relief. - TCAs have significant **anticholinergic side effects** and cardiotoxicity, making them less suitable for immediate use in an acute panic attack. *Metoprolol* - **Metoprolol** is a **beta-blocker** that can help manage the physical symptoms of anxiety, such as palpitations and tremors, but it does not address the underlying psychological component of panic. - Beta-blockers are generally not recommended as monotherapy for panic attacks as they do not treat the core anxiety, though they can be useful for performance anxiety. *Bupropion* - **Bupropion** is an **atypical antidepressant** primarily used for depression and smoking cessation, but it can sometimes worsen anxiety in patients. - It works by inhibiting the reuptake of norepinephrine and dopamine, and its stimulant-like effects are not suitable for acute panic relief. *Nifedipine* - **Nifedipine** is a **calcium channel blocker** used to treat hypertension and angina, and it has no direct role in the management of panic attacks. - While it affects cardiovascular function, it does not alleviate the anxiety and fear component of a panic attack.
Explanation: ***Cognitive behavioral therapy*** - The patient exhibits classic symptoms of **social anxiety disorder (social phobia)**, including anxiety in social situations, fear of judgment, and avoidance behavior, which is a key indication for **CBT**. - **CBT** is an effective first-line treatment for social anxiety, helping individuals identify and challenge distorted thoughts, and gradually expose themselves to feared social situations. *Buspirone therapy* - **Buspirone** is an anxiolytic that can be used for **generalized anxiety disorder**, but it is generally less effective for specific phobias like social anxiety or for acute anxiety attacks. - Its therapeutic effects can take several weeks to manifest, making it unsuitable for immediate symptom management in highly specific, performance-related anxiety. *Lorazepam therapy* - **Lorazepam**, a **benzodiazepine**, can acutely reduce anxiety symptoms but carries risks of **tolerance, dependence, and withdrawal**, especially with frequent use. - Its potential for abuse, combined with the patient's marijuana use for nerves, makes it a less appropriate first-line choice for long-term management. *Duloxetine therapy* - **Duloxetine**, a **serotonin-norepinephrine reuptake inhibitor (SNRI)**, is a pharmacological option for social anxiety disorder, particularly when CBT alone is insufficient. - While an antidepressant, it is not considered the initial treatment of choice over CBT, which addresses the underlying cognitive and behavioral patterns. *Olanzapine therapy* - **Olanzapine** is an **atypical antipsychotic** primarily used for conditions like **schizophrenia** and **bipolar disorder**. - It is not indicated for social anxiety disorder as a standalone treatment and carries significant side effects, including metabolic disturbances.
Explanation: ***Social anxiety disorder*** - This patient exhibits characteristic symptoms of **social anxiety disorder**, including significant anxiety in social situations (e.g., public speaking in class), fear of being judged negatively, and resulting avoidance behaviors (skipping class). - The physical symptoms (palpitations, sweating, blushing, nausea) are typical physiological responses to social performance anxiety, and the 1-year history indicates a chronic pattern. *Schizotypal personality disorder* - Characterized by pervasive patterns of social and interpersonal deficits marked by **acute discomfort with, and reduced capacity for, close relationships**, as well as cognitive or perceptual distortions and eccentric behavior. - The patient's symptoms are primarily anxiety-driven in social contexts, not due to thought disorders, magical thinking, or eccentric behaviors common in schizotypal personality disorder. *Generalized anxiety disorder* - Involves **excessive, uncontrollable worry** about a variety of events or activities, often not specific to social situations. - While the patient has anxiety, it is specifically triggered by social performance and evaluation, distinguishing it from the pervasive, non-specific worry of generalized anxiety disorder. *Normal shyness* - While the patient is shy, her symptoms are severe enough to cause **significant distress and functional impairment**, such as skipping classes and avoiding activities she once enjoyed (jogging). - Normal shyness typically does not lead to this level of avoidance or functional compromise, nor does it typically present with such intense physiological symptoms. *Avoidant personality disorder* - While both social anxiety disorder and avoidant personality disorder involve social avoidance, the latter is a more pervasive pattern involving a **deep-seated sense of inadequacy, hypersensitivity to negative evaluation**, and a fear of intimacy across many social contexts. - The symptoms described are more acutely tied to **performance and scrutiny** in social situations rather than a global pattern of avoidant behaviors stemming from a core sense of inadequacy.
Explanation: ***Cognitive behavioral therapy*** - **Cognitive Behavioral Therapy (CBT)** is considered a first-line psychological treatment for **Post-Traumatic Stress Disorder (PTSD)**, which the patient's symptoms (deployments, intrusive thoughts, nightmares, avoidance, guilt) strongly suggest. - CBT helps individuals identify and challenge **maladaptive thought patterns** and behaviors related to the trauma, fostering new coping mechanisms. *Dialectical behavioral therapy* - **Dialectical Behavioral Therapy (DBT)** is primarily used for individuals with **Borderline Personality Disorder** or severe emotional dysregulation. - While it can help with emotional regulation, it is not the **first-line therapy** specifically targeting trauma-related cognitive distortions and avoidance behaviors seen in PTSD. *Venlafaxine therapy* - **Venlafaxine**, an SNRI, is an antidepressant that can be effective for PTSD symptoms. However, current guidelines recommend **psychotherapy (like CBT)** as the initial step, especially when feasible. - While pharmacotherapy can be used, it's typically considered **adjunctive** or for cases where psychotherapy alone is insufficient or not preferred. *Motivational interviewing* - **Motivational interviewing** is a patient-centered counseling style used to address ambivalence and enhance a person's **intrinsic motivation** for change. - It is often utilized in substance abuse treatment or when patients are resistant to treatment, but it is not a primary, standalone treatment for the core symptoms of PTSD. *Prazosin therapy* - **Prazosin** is an alpha-1 antagonist used off-label to treat **PTSD-related nightmares** and sleep disturbances. - While it can be helpful for a specific symptom, it does not address the broader spectrum of PTSD symptoms, such as intrusive thoughts, avoidance, or negative cognitions.
Explanation: ***Naltrexone*** - This patient exhibits symptoms consistent with **alcohol use disorder**, including increased tolerance, problematic use despite negative consequences (car accident, daughter's concern), and use to alleviate withdrawal-like symptoms (anxiety, poor sleep, handshaking, sweating). **Naltrexone** helps reduce **craving and pleasurable effects of alcohol** by blocking opioid receptors. - Given that she has never tried stopping and does not endorse severe withdrawal symptoms requiring inpatient detoxification typically, naltrexone is a suitable first-line pharmacotherapy for **alcohol use disorder** in this context. *Topiramate* - While **topiramate** can be used as an off-label treatment for alcohol use disorder, particularly in reducing heavy drinking and cravings, it is generally considered a second-line option. - Its side effect profile can be more notable (e.g., cognitive slowing, paresthesias) compared to naltrexone, and it's less commonly chosen as an initial monotherapy when other options are available. *Amitriptyline* - **Amitriptyline** is a tricyclic antidepressant primarily used for **depression** and some **neuropathic pain** conditions. - It is not indicated for the treatment of **alcohol use disorder** and could potentially worsen some symptoms or interact with alcohol. *Gabapentin* - **Gabapentin** is sometimes used off-label for **alcohol use disorder**, particularly for managing withdrawal symptoms, reducing cravings, and improving sleep. - However, for a patient who has never attempted cessation and is not in acute withdrawal, but rather is seeking to reduce problematic drinking, naltrexone is generally preferred as a first-line agent. *Disulfiram* - **Disulfiram** works by causing an unpleasant physical reaction (nausea, vomiting, flushing, palpitations) when alcohol is consumed. - It requires strong patient motivation and adherence, as the patient must avoid all alcohol. Given her current struggle with moderation and no prior attempts at abstinence, beginning with disulfiram, which relies on aversive conditioning, might be challenging and is often reserved for highly motivated patients or those who have failed other treatments.
Explanation: ***Decreased level of serotonin*** - Obsessive-compulsive disorder (OCD), characterized by **obsessions (intrusive thoughts)** and **compulsions (repetitive behaviors)**, is strongly linked to dysregulation of the **serotonin system**. - Medications that **increase serotonin levels**, such as selective serotonin reuptake inhibitors (SSRIs), are the first-line pharmacologic treatment for OCD. *Atrophy of the hippocampus* - **Hippocampal atrophy** is more commonly associated with conditions like **Alzheimer's disease** and other dementias, affecting memory and learning. - It is not a primary neurobiological feature of OCD. *Atrophy of the frontotemporal lobes* - **Frontotemporal lobe atrophy** is characteristic of **frontotemporal dementia**, leading to changes in personality, behavior, and language. - This is distinct from the symptom presentation of OCD. *Enlargement of the ventricles* - **Ventricular enlargement** is most commonly seen in conditions like **schizophrenia** and **hydrocephalus**, indicating a loss of brain tissue or increased cerebrospinal fluid pressure. - It is not a typical finding in OCD. *Increased activity of the caudate* - While there are neuroimaging studies suggesting **increased caudate nucleus activity** in OCD, this is a distinct phenomenon from decreased serotonin levels. - **Increased activity in the orbitofrontal cortex, anterior cingulate cortex, and basal ganglia (including the caudate)** are structural and functional abnormalities often observed, but the primary biochemical imbalance widely targeted in treatment is serotonin.
Explanation: ***Dental cavities*** - The patient's presentation, including **body image distortion**, low-normal BMI, irregular menses, dark circles under her eyes, and calluses on the dorsum of the hand (**Russell's sign** from inducing vomiting), strongly suggests **bulimia nervosa**. - **Frequent self-induced vomiting** exposes teeth to gastric acid (pH ~2), leading to **dental enamel erosion**, particularly on the lingual surfaces of teeth, and significantly increased risk of **dental cavities**. - This is a **characteristic complication** of bulimia nervosa with purging behavior. *Motor tics* - **Motor tics** are involuntary, sudden, rapid, recurrent, nonrhythmic movements, typically associated with **Tourette's syndrome** or other tic disorders. - They are **not associated** with eating disorders like bulimia nervosa. *Metatarsal stress fractures* - **Stress fractures** can occur in eating disorders but are more characteristic of **anorexia nervosa** with significant weight loss, malnutrition, and resulting **osteopenia/osteoporosis**. - In **bulimia nervosa**, patients typically maintain **normal or near-normal body weight** (this patient's BMI is 19, which is low-normal), making stress fractures less common compared to anorexia nervosa. - While this patient is an athlete (which increases stress fracture risk), dental complications from purging are more directly associated with her likely diagnosis. *Lanugo* - **Lanugo** (fine, downy body hair) is a compensatory response to hypothermia and loss of subcutaneous fat. - It is characteristically seen in **anorexia nervosa** with severe weight loss (BMI typically <17 kg/m²). - In **bulimia nervosa**, patients maintain normal or near-normal weight, so lanugo is **rarely present**. *Galactorrhea* - **Galactorrhea** (inappropriate lactation) is typically caused by **hyperprolactinemia**, certain medications (e.g., antipsychotics, metoclopramide), or pituitary disorders. - It is **not a recognized complication** of bulimia nervosa or other eating disorders.
Explanation: ***Delayed sleep-wake disorder*** - This patient exhibits a consistent pattern of **delayed sleep onset** and **delayed wake time**, particularly evident on weekends when he can follow his natural circadian rhythm (going to bed at 2 AM and waking at 10 AM). - The symptoms, including difficulty falling asleep at conventional times, difficulty waking for school, and daytime sleepiness, are classic for **delayed sleep-wake phase disorder**, where an individual's internal clock is misaligned with societal expectations. *Inadequate sleep hygiene* - While aspects like studying in bed are **poor sleep hygiene**, the core issue is not simply bad habits but a fundamental misalignment of his **circadian rhythm** as evidenced by his consistent late sleep onset and wake times when allowed. - The patient's ability to sleep well and feel rested on weekends when he can follow his natural rhythm suggests that hygiene alone isn't the primary cause. *Irregular sleep-wake disorder* - This disorder is characterized by a **lack of a discernible sleep-wake rhythm**, with sleep periods fragmented and scattered throughout the 24-hour day. - The patient, however, demonstrates a clear, albeit delayed, sleep schedule; he sleeps in one consolidated block and feels rested when allowed to do so. *Psychophysiologic insomnia* - This condition involves heightened arousal and **anxiety surrounding sleep**, leading to difficulty falling asleep at night and often improved sleep in novel environments or away from home. - While he expresses worry about not getting enough sleep, his sleep issues are primarily due to a shifted circadian phase, not just anxiety about sleep itself, and he sleeps restfully when allowed to follow his delayed rhythm. *Advanced sleep-wake disorder* - This disorder is characterized by a **habitually early sleep onset** and **early morning awakening**, typically several hours earlier than desired or conventional times. - The patient, in contrast, consistently struggles to fall asleep until very late hours and desires a later wake time.
Explanation: ***Panic disorder*** - The patient experiences **recurrent, unprovoked panic attacks** characterized by palpitations, feelings of dread, and lightheadedness, which align with the diagnostic criteria for panic disorder. - His behavior of sitting at the back of lecture halls to "quickly escape" indicates **avoidance behaviors** and **anticipatory anxiety** related to potential future attacks, a hallmark of panic disorder. *Social phobia* - This condition is characterized by **fear or anxiety about social situations** where the individual might be scrutinized or judged, which is not the primary driver of the patient's symptoms or avoidance behavior. - While he avoids public situations, his motivation is fear of a panic attack, not fear of social judgment. *Specific phobia* - This involves an **intense, irrational fear of a specific object or situation** (e.g., heights, spiders, flying), which does not fit the generalized, unprovoked nature of the patient's panic attacks. - The patient's symptoms are not tied to a single, clearly defined phobic stimulus. *Adjustment disorder* - This diagnosis is typically made when individuals experience **emotional or behavioral symptoms in response to an identifiable stressor**, arising within three months of the onset of the stressor. - While starting college is a stressor, the patient's panic attacks are recurrent and unprovoked, evolving into a pattern beyond a typical adjustment response, and he has a negative cardiac workup. *Somatic symptom disorder* - This involves **distressing somatic symptoms accompanied by excessive thoughts, feelings, or behaviors related to the symptoms**, such as disproportionate thoughts about the seriousness of one's symptoms or high levels of anxiety about health. - Although the patient experiences physical symptoms (palpitations), the presence of clear panic attacks, dread, and avoidance behavior points more specifically to panic disorder rather than a primary focus on the somatic symptoms themselves.
Explanation: ***The patient is annoyed by the doctor because he feels the doctor is lecturing like his mother used to do*** - This is a classic example of **transference**, where the patient unconsciously projects feelings and attitudes from significant past relationships (like with a parent) onto the therapist. - The patient is reacting to the doctor not based on the doctor's current behavior, but through the lens of past experiences with their **mother's lecturing style**. *The patient feels powerless to change and blames his problems on the situation into which he was born* - This describes an **external locus of control** and possibly a sense of learned helplessness, but it doesn't involve projecting past relational patterns onto the therapist. - While it's a patient's feeling, it's about their life situation rather than their perception of the therapist based on past figures. *The doctor feels that the patient's unwillingness to change is frustrating as it is similar to the feelings the doctor has towards his/her child with behavior problems* - This scenario describes **countertransference**, where the **therapist's** unresolved issues or feelings towards significant others (like their child) are projected onto the patient. - Transference specifically refers to the patient's projection, not the therapist's. *The patient feels that her father is too controlling and interferes with all aspects of her life* - This is a direct statement about the patient's current relationship with her father, or a past experience, and does not involve projecting these feelings onto the **therapist**. - While it might be a topic explored in therapy, it's not a manifestation of transference *within* the therapeutic relationship itself. *The doctor has feelings of sexual attraction towards the patient* - This is an example of **countertransference**, as it describes the **therapist's** feelings towards the patient, rather than the patient's feelings towards the therapist. - Such feelings, especially sexual attraction, are considered unethical in therapy and need to be managed by the therapist.
Explanation: ***Generalized anxiety disorder*** - This patient presents with **chronic, excessive, and uncontrollable worry** about multiple life circumstances (job, marriage, children, finances), fulfilling the core diagnostic criterion for GAD. - The associated symptoms of **muscle pains**, **poor sleep**, and **daytime fatigue** are common physical manifestations of GAD, and the duration of symptoms for over a year supports the diagnosis. *Social phobia* - **Social phobia**, or social anxiety disorder, involves intense fear and anxiety in **social situations** where one might be scrutinized or judged. - The patient's reported worries are broad and not limited to social interactions, making social phobia less likely. *Adjustment disorder* - **Adjustment disorder** is characterized by emotional or behavioral symptoms developing within **three months of an identifiable stressor**, not diffuse chronic worry. - The symptoms in adjustment disorder typically resolve within **six months** after the stressor or its consequences have ended, whereas this patient's symptoms are chronic and pervasive. *Obsessive-compulsive disorder* - **Obsessive-compulsive disorder (OCD)** involves recurrent, intrusive **obsessions** (thoughts, urges, images) and/or **compulsions** (repetitive behaviors or mental acts) performed to reduce anxiety. - While the patient experiences severe worrying, there's no mention of specific obsessions or compulsive behaviors aimed at neutralizing those anxieties. *Panic disorder* - **Panic disorder** is characterized by recurrent, unexpected **panic attacks**—sudden surges of intense fear or discomfort accompanied by physical and cognitive symptoms. - While the patient uses the term "panics," she clarifies it involves "severe worrying," not discrete, intense, and short-lived panic attacks.
Explanation: ***Prescribe fluoxetine*** * The patient's presentation with recurrent, unprovoked episodes of **choking sensation, palpitations, sweating, and shortness of breath**, lasting about 10 minutes, and leading to avoidance behavior (agoraphobia), is highly consistent with **panic disorder with agoraphobia**. * **Selective serotonin reuptake inhibitors (SSRIs)** like fluoxetine are first-line pharmacologic treatments for panic disorder, demonstrating efficacy in reducing the frequency and severity of panic attacks. *Administer lorazepam* * **Lorazepam** is a **benzodiazepine** that can provide rapid relief of acute panic symptoms due to its anxiolytic effects. * However, it is typically used for **acute symptom management** or short-term bridging therapy due to the risk of **dependence, tolerance, and withdrawal**, and is not considered a first-line long-term solution for panic disorder. *Administer propranolol* * **Propranolol** is a **beta-blocker** that can alleviate some physical symptoms of anxiety, such as palpitations and tremor, by blocking adrenergic receptors. * It is more commonly used for **performance anxiety** or specific phobias and does not address the core psychological components of panic disorder or the avoidance behaviors associated with agoraphobia. *D-dimer measurement* * **D-dimer measurement** is used to rule out **thrombotic events** such as deep vein thrombosis (DVT) or pulmonary embolism (PE). * The patient's symptoms are episodic, resolve spontaneously, and are not continuous or worsening, and previous ED evaluations for cardiovascular issues were normal, making a thrombotic event unlikely in this context. *Echocardiography* * **Echocardiography** is an imaging test to evaluate the **structure and function of the heart**. * Given that the patient's ECG was normal, cardiac enzymes were normal, and she has experienced several such episodes without cardiac dysfunction, further cardiac workup like echocardiography is unlikely to reveal an underlying cardiac cause and would be an unnecessary investigation at this point.
Explanation: ***Correct: Trichotillomania*** - This is a **hair-pulling disorder** classified as an obsessive-compulsive related disorder in which individuals repeatedly pull out their own hair. - The diagnostic features in this case are highly characteristic: **ill-defined patchy hair loss with hairs of different lengths** (indicating repeated pulling over time), absence of scalp inflammation (no scaling or redness), and involvement of **eyebrows and eyelashes**. - The patient's recent emotional stressor (breakup) is a common **precipitating factor** for this impulse control behavior, particularly in adolescents. - The lack of itching and inflammatory changes helps distinguish this from dermatological causes of hair loss. *Incorrect: Telogen effluvium* - This condition presents with **diffuse hair shedding** following a significant physiological or emotional stressor (typically 2-3 months after the trigger). - While stress can precipitate telogen effluvium, it causes **uniform hair thinning** across the scalp rather than distinct patches with hairs of different lengths. - The patchy distribution and varying hair lengths are inconsistent with telogen effluvium. *Incorrect: Alopecia areata* - An autoimmune condition characterized by **well-demarcated, smooth, circular patches** of complete hair loss, often with "exclamation point hairs" at the margins. - While it can affect eyebrows and eyelashes, the description of **"ill-defined" patches with hairs of different lengths** is atypical for alopecia areata, which typically shows complete hair loss in well-circumscribed areas. - The patches in alopecia areata are usually round and sharply defined, not ill-defined. *Incorrect: Scarring alopecia* - Involves **permanent destruction of hair follicles** with fibrosis, leading to smooth, atrophic patches where hair cannot regrow. - Usually presents with **visible scarring, scaling, erythema, or signs of inflammation** on the scalp. - The absence of any inflammatory changes, scaling, or scarring on examination makes this diagnosis unlikely. *Incorrect: Tinea capitis* - A **fungal infection** of the scalp that typically presents with scaling, erythema, and broken hairs, often accompanied by pruritus. - Characteristic findings include **"black dot" pattern** (broken hairs at scalp surface), cervical lymphadenopathy, and inflammatory changes. - The patient's lack of itching and absence of scaling or redness effectively rule out this diagnosis.
Explanation: ***Post-traumatic stress disorder*** - The patient's symptoms, including **re-experiencing the trauma** (nightmares, flashbacks), avoidance behaviors (avoiding driving, withdrawing from social interactions), and negative alterations in cognition and mood (difficulty sleeping, self-blame), persisting for **four months** after a traumatic event, are characteristic of PTSD. - The severity and chronicity of these symptoms, significantly impacting her daily functioning, align with the diagnostic criteria for PTSD. *Acute stress disorder* - This diagnosis also involves exposure to a traumatic event and similar symptoms (intrusive thoughts, negative mood, avoidance) but is diagnosed only when symptoms last for a minimum of **3 days and a maximum of 1 month** after the trauma. - Since the patient's symptoms have persisted for **four months**, acute stress disorder is ruled out. *Normal grief* - While grief is a natural response to loss, the patient's symptoms extend beyond typical grief, involving specific **trauma-related re-experiencing** and **avoidance behaviors** that are not primarily focused on the deceased, but rather on the traumatic event itself. - Normal grief typically does not involve the severe, persistent avoidance and intrusive symptoms of a traumatic nature seen here. *Major depressive disorder* - Although the patient exhibits symptoms that could overlap with depression (difficulty sleeping, withdrawal, loss of interest), the primary driver of her symptoms is the **traumatic event** and its associated re-experiencing and avoidance. - A diagnosis of MDD would be considered if the depressive symptoms are paramount and not better explained by the trauma response, but in this case, the **trauma-specific symptoms** are central. *Adjustment disorder* - This disorder is characterized by the development of emotional or behavioral symptoms in response to an identifiable stressor, occurring within **3 months of the stressor**. - While a traumatic event could be a stressor, adjustment disorder is diagnosed when the symptoms **do not meet the criteria for another specific mental disorder**, like PTSD, and are generally less severe and pervasive than what is described in this patient.
Explanation: ***Avoidant personality disorder*** - Characterized by **social inhibition**, feelings of **inadequacy**, and **hypersensitivity to negative evaluation**, leading to avoidance of social interactions despite a desire for connection. - The patient's self-perception, sensitivity to criticism, and absence of romantic relationships are classic signs. *Schizoid personality disorder* - Individuals with schizoid personality disorder exhibit a pervasive pattern of **detachment from social relationships** and a restricted range of emotional expression. - Unlike avoidant personality disorder, they typically **do not desire social connection** and are indifferent to criticism or praise. *Paranoid personality disorder* - Marked by pervasive **distrust and suspiciousness of others**, interpreting their motives as malevolent. - This patient's symptoms are more focused on self-perception and social anxiety rather than paranoid ideation. *Depression* - Depression involves a sustained period of **low mood**, loss of interest or pleasure, and other vegetative symptoms, which are not explicitly described as the primary, long-standing issue here. - While feelings of worthlessness can occur in depression, the chronic, pervasive social inhibition and desire for relationships point away from a primary depressive episode as the sole diagnosis. *Dysthymia* - Dysthymia, or persistent depressive disorder, is characterized by a chronically depressed mood for at least two years, but it usually includes more pervasive depressive symptoms like low energy and anhedonia. - While it can involve poor self-esteem, it doesn't fully explain the specific pattern of social avoidance and hypersensitivity to criticism, especially the patient's desire for social connection, which is often dampened in dysthymia.
Explanation: ***Cognitive behavioral therapy*** - **Cognitive Behavioral Therapy (CBT)**, specifically exposure therapy, is the **first-line treatment** for specific phobias due to its high efficacy in reducing fear and avoidance. - The patient's significant interference with daily activities and panic attacks necessitate a direct and effective intervention like CBT. *Benzodiazepines* - **Benzodiazepines** can provide short-term relief for acute anxiety, but they do not address the underlying phobia and have a **risk of dependence** and withdrawal symptoms. - They are generally not recommended as a first-line or monotherapy for specific phobias because they can interfere with the learning process of exposure therapy. *Antidepressants* - **Antidepressants**, particularly SSRIs, are effective for generalized anxiety disorder or panic disorder but are **not typically first-line for specific phobias** unless there are co-occurring conditions. - Their action mechanism is slower, and they are less effective than exposure therapy for specific phobias. *Beta-blockers* - **Beta-blockers** help manage the **physical symptoms of anxiety** (e.g., palpitations, tremors) but do not address the psychological component of specific phobias. - They are used symptomatically and are not a cure for the phobia itself. *Anxiolytics* - **Anxiolytics** is a broad term that includes benzodiazepines; while they can reduce anxiety, they are **not a primary treatment** for specific phobias and carry risks. - For specific phobias, the goal is not just symptom reduction but overcoming the fear through behavioral changes, which anxiolytics do not facilitate.
Explanation: ***Sleep hygiene education*** - This is the **best initial step** because it addresses lifestyle factors that commonly contribute to **insomnia and fatigue**, especially during periods of stress like final exams. - Helping the patient establish **regular sleep patterns**, avoid stimulants, and create a conducive sleep environment can significantly improve sleep quality without medication. *Polysomnography* - This is a diagnostic test typically reserved for when a **primary sleep disorder** like sleep apnea or restless legs syndrome is suspected. - Given the patient's acute stressor (final exams) and **drug use**, lifestyle interventions should be tried first before pursuing expensive and invasive testing. *Alprazolam* - This is a **benzodiazepine** that can be used for acute anxiety or insomnia, but it carries a risk of **dependence, tolerance, and withdrawal**. - It is not a first-line treatment for a patient experiencing sleep difficulties primarily due to stress and poor sleep habits, and its use should be avoided in those with a history of substance abuse. *Melatonin* - Melatonin can be helpful for **circadian rhythm disorders** or jet lag, but its efficacy for primary insomnia is limited and inconsistent. - While it has fewer side effects than prescription hypnotics, **sleep hygiene education** is still a more fundamental and effective initial approach for this patient. *Zolpidem* - This is a **non-benzodiazepine hypnotic** often prescribed for short-term insomnia, but it has potential side effects like **next-day drowsiness** and can be abused, especially in individuals with a history of substance use. - **Sleep hygiene** should always be optimized first, especially in a young patient whose sleep issues are clearly linked to stress and lifestyle.
Explanation: ***Gitelman syndrome*** - The patient presents with **hypokalemia**, **metabolic alkalosis** (bicarbonate = 29 mEq/L), and **hypochloremia** (chloride = 97 mEq/L), which are characteristic features. - The **low urine chloride** (4 mEq/L) and **low urine sodium** (11 mEq/L) despite normal blood pressure indicate renal tubular dysfunction resembling the effect of **thiazide diuretics**. - Gitelman syndrome is associated with **hypocalciuria** and typically presents in adolescence or young adulthood, often with a family history of renal disease. *Bartter syndrome* - Typically presents with **hypokalemia**, **metabolic alkalosis**, and **hypochloremia**, similar to Gitelman syndrome. - However, Bartter syndrome usually presents in **infancy or early childhood** and is associated with **hypercalciuria** (vs. hypocalciuria in Gitelman), which helps differentiate the two conditions. - The adolescent presentation and family history of renal disease favor Gitelman syndrome. *Anorexia nervosa* - Patients with anorexia nervosa often present with a very **low BMI** (<17.5 kg/m^2) and may have electrolyte imbalances due to starvation or purging behaviors. - This patient's BMI is normal (23 kg/m^2), and there are no other signs suggesting an eating disorder like amenorrhea, bradycardia, or lanugo. *Diuretic abuse* - While **diuretic abuse** can cause hypokalemia, metabolic alkalosis, and hypochloremia, active diuretic use would typically show **elevated urine chloride** (>20 mEq/L). - The **low urine chloride** (4 mEq/L) in this case suggests either remote diuretic use or, more likely, a chronic tubular defect like Gitelman syndrome. - No history of diuretic access or suspicious behavior is mentioned, and the presentation with family history points towards a congenital tubulopathy. *Bulimia nervosa* - Bulimia nervosa involves recurrent episodes of **binge eating followed by compensatory behaviors** like vomiting, laxative abuse, or excessive exercise. - While it can cause hypokalemia and metabolic alkalosis due to vomiting, the patient's normal BMI, lack of any suggestive signs (e.g., dental erosions, Russell's sign, parotid gland enlargement), and the specific pattern of low urine chloride make this diagnosis less likely.
Explanation: ***Somatic symptom disorder*** - The patient presents with multiple unexplained physical symptoms (chronic back pain, abdominal bloating, constipation, episodic chest pain) over an extended period. Despite normal physical examinations, laboratory studies, and imaging, he continues to have significant distress and concern about serious medical conditions (e.g., pancreatic cancer), consistent with **somatic symptom disorder**. - His history of job-related stress, frequent performance evaluations, and the anxiety leading him to seek reassurance and extensive internet research further support the diagnosis of illness preoccupation and persistent somatic symptoms without a clear medical cause. *Acute stress disorder* - This disorder typically develops within **1 month** of exposure to a **traumatic event** and resolves within that timeframe. - The patient's symptoms are chronic (1 year of back pain), unrelated to a specific traumatic event, and do not fit the time course of acute stress disorder. *Atypical depression* - Atypical depression is characterized by mood reactivity (mood improves in response to positive events), increased appetite/weight gain, hypersomnia, leaden paralysis, and interpersonal rejection sensitivity. - While the patient is under stress, his primary presentation revolves around physical symptoms and health anxiety, not the core features of atypical depression. *Irritable bowel syndrome* - Although the patient's abdominal bloating and constipation are consistent with irritable bowel syndrome (IBS), IBS alone would not explain his chronic back pain, episodic chest pain, and the pervasive health anxiety with repeated medical evaluations. - IBS is a diagnosis of exclusion and a component of a broader picture in this patient, not the sole or primary explanation of all his symptoms. *Malignant neoplasm* - The patient's thorough medical evaluations, including normal laboratory studies and an X-ray of the spine, along with a normal physical examination, make a malignant neoplasm highly unlikely. - His symptoms also lack typical red flags for malignancy, such as unexplained weight loss, fever, or night sweats.
Explanation: ***Avoidant Personality Disorder*** - This patient exhibits a pervasive pattern of **social inhibition**, feelings of **inadequacy**, and **hypersensitivity to negative evaluation**, consistent with Avoidant Personality Disorder. Her shyness, fear of criticism, avoidance of social interaction, and belief that others will find her unappealing are key indicators. - The symptoms are long-standing ("as long as she can remember") and pervasive across different situations (college, work, personal life), meeting the diagnostic criteria for a **personality disorder**. *Adjustment disorder with depressed mood* - An **adjustment disorder** typically arises in response to an identifiable stressor and begins within three months of the stressor's onset, resolving once the stressor is removed or a new level of adaptation is achieved. - The patient's symptoms are chronic and long-standing, not attributable to a recent stressor, and therefore do not fit this diagnosis. *Dependent personality disorder* - Individuals with **Dependent Personality Disorder** exhibit an excessive need to be cared for, leading to submissive and clinging behaviors and fears of separation. They often struggle to make decisions and require constant reassurance. - While the patient expresses worry about not finding a boyfriend who thinks she is good enough, her primary motivation for social avoidance is fear of criticism and inadequacy, not a pervasive need for care or fear of abandonment. *Social anxiety disorder* - **Social Anxiety Disorder** (Social Phobia) involves intense fear or anxiety about social situations in which the individual may be scrutinized by others, leading to avoidance or endurance with great distress. - While there is overlap, Avoidant Personality Disorder is characterized by a more pervasive and deeply ingrained sense of **self-inadequacy** and shame, leading to a broader pattern of social avoidance, whereas social anxiety disorder is primarily driven by performance-related fears in specific social situations. The chronic and pervasive nature of the patient's self-perception aligns more with a personality disorder. *Schizoid personality disorder* - **Schizoid Personality Disorder** is characterized by a pervasive pattern of detachment from social relationships and a restricted range of emotional expression. Individuals with schizoid personality disorder typically show no desire for close relationships and are indifferent to the approval or criticism of others. - This patient desires relationships (expressing worry about finding a boyfriend) but avoids them due to fear of criticism and inadequacy, which is distinct from the lack of desire for relationships seen in **Schizoid Personality Disorder**.
Explanation: ***Cognitive behavioral therapy*** - This patient's symptoms are highly suggestive of **panic disorder**, characterized by recurrent, unexpected panic attacks and persistent worry about future attacks. **Cognitive behavioral therapy (CBT)** is considered **first-line treatment** for panic disorder, especially for long-term management, as it addresses the underlying thought patterns and behaviors. - CBT, particularly exposure therapy, helps patients **reframe their catastrophic thoughts** and directly confront situations that trigger anxiety, leading to a significant reduction in panic attack frequency and severity. It is a good choice for this patient since he has had problems with medication compliance. *Alprazolam* - **Alprazolam** is a **benzodiazepine** that provides rapid symptom relief during acute panic attacks but is generally not recommended as first-line for long-term management due to its **potential for dependence**, tolerance, and withdrawal symptoms. - Its short half-life can lead to rebound anxiety, and it does not address the underlying cognitive distortions common in panic disorder. *Imipramine* - **Imipramine** is a **tricyclic antidepressant (TCA)** that can be effective for panic disorder, but it is **not generally a first-line pharmacotherapy** due to its more significant side effect profile (e.g., anticholinergic effects, cardiac toxicity in overdose) compared to SSRIs. - The patient's history of medication non-compliance due to side effects makes this a less suitable long-term option compared to CBT. *Fluoxetine* - **Fluoxetine** is a **selective serotonin reuptake inhibitor (SSRI)**, which is often considered first-line pharmacotherapy for panic disorder due to its efficacy and generally favorable side effect profile. However, given the patient's strong preference against medication and history of non-compliance, CBT would be the preferred initial long-term strategy. - While effective, SSRIs generally take several weeks to reach full therapeutic effect, and the patient may still experience initial side effects, further contributing to potential non-compliance. *Buspirone* - **Buspirone** is an **anxiolytic** that is effective for generalized anxiety disorder but is **not considered first-line for panic disorder**. - It has a slower onset of action and is typically less effective in treating the acute, intense symptoms of panic attacks compared to other agents.
Explanation: ***Risperidone*** - The patient presents with classic symptoms of **Obsessive-Compulsive Disorder (OCD)**, including intrusive thoughts (preoccupation with failing) and compulsive behaviors (checking textbooks). When a first-line SSRI is ineffective after an adequate trial (8-12 weeks), **augmentation with an atypical antipsychotic** is the evidence-based next step. - **Risperidone** (along with aripiprazole) has the strongest evidence for augmenting SSRIs in treatment-resistant OCD. It helps reduce the severity of **obsessive thoughts** and **compulsive actions** by modulating dopamine and serotonin pathways. - The family history of **Tourette's syndrome** further supports this choice, as both conditions share genetic links and respond to dopamine modulation. *Sertraline* - **Sertraline** is a **first-line selective serotonin reuptake inhibitor (SSRI)** for OCD. The patient in the vignette has already been on a first-line medication for eight weeks, implying an initial SSRI was ineffective. - Adding another SSRI like sertraline when one has already failed is generally not the next step in managing refractory OCD; augmentation with a different class of medication (atypical antipsychotic) is the preferred strategy. *Propranolol* - **Propranolol** is a **beta-blocker** primarily used to manage symptoms of anxiety such as **tremors**, **palpitations**, and **social anxiety** by reducing peripheral adrenergic effects. - It does not directly address the core obsessive thoughts or compulsive behaviors characteristic of OCD and is not considered a primary treatment or augmentation strategy for this disorder. *Methylphenidate* - **Methylphenidate** is a **stimulant** medication primarily used to treat **Attention-Deficit/Hyperactivity Disorder (ADHD)** and **narcolepsy**. - It is not indicated for the treatment of OCD and could potentially exacerbate anxiety or sleep disturbances in this patient. *Phenelzine* - **Phenelzine** is a **monoamine oxidase inhibitor (MAOI)**, an older class of antidepressants. While MAOIs can be effective for some anxiety disorders, they are not first-line for OCD due to their significant side effect profile and dietary restrictions (**tyramine-free diet**). - MAOIs are generally reserved for highly refractory cases of depression or anxiety and are not a standard augmentation strategy when an SSRI has failed for OCD, especially before trying atypical antipsychotics.
Explanation: ***Post-traumatic stress disorder (PTSD)*** - The patient's symptoms of **nightmares**, **flashbacks** (re-experiencing the trauma), **difficulty sleeping**, and **impaired concentration** following severe trauma are characteristic of PTSD. - The symptoms have persisted for **6 weeks** (more than 1 month), meeting the duration criterion for PTSD diagnosis. *Schizophrenia* - Schizophrenia is characterized by **psychotic symptoms** such as hallucinations, delusions, and disorganized thought/speech, which are not described in this patient. - While stress can exacerbate schizophrenia, the patient's symptoms are directly tied to a specific traumatic event, not a chronic psychotic disorder. *Normal reaction to trauma* - While some distress is expected after trauma, the presence of **persistent re-experiencing symptoms** (nightmares, flashbacks), and hyperarousal symptoms lasting for **over a month** is beyond a normal, transient reaction. - These symptoms significantly impair the patient's functioning and indicate a clinically significant disorder. *Acute stress disorder* - Acute stress disorder presents with similar symptoms to PTSD, including intrusive thoughts, negative mood, dissociation, avoidance, and arousal. - However, acute stress disorder is diagnosed when symptoms occur **3 days to 1 month** after trauma exposure; this patient's symptoms have lasted **6 weeks**, exceeding the 1-month threshold for ASD and meeting criteria for PTSD. *Schizophreniform disorder* - Schizophreniform disorder involves psychotic symptoms like **hallucinations, delusions, or disorganized speech**, lasting between 1 and 6 months. - The patient's symptoms are primarily related to trauma re-experiencing and hyperarousal, not psychotic features.
Explanation: ***Dissociative amnesia with dissociative fugue*** - This diagnosis is strongly suggested by the patient's sudden, unexpected travel away from home accompanied by an inability to recall her past, including her personal identity, and confusion about her new identity or assumption of a new identity. The stress and prior depressive episodes are contributing factors. - The patient's inability to recognize her husband or recall significant life events, combined with intact short-term memory and normal physical/neurological exams, fits the criteria for **dissociative amnesia**, and the travel indicates **dissociative fugue specifier** (DSM-5 terminology). *Dissociative identity disorder* - This disorder is characterized by the presence of two or more distinct personality states (or "alters"), each with its own relatively enduring pattern of perceiving, relating to, and thinking about the environment and self. This patient does not exhibit multiple distinct identities. - While there is amnesia associated with this disorder, it typically involves switching between alters and their associated memories, which is not described here. *Depersonalization/derealization disorder* - This condition involves persistent or recurrent experiences of feeling detached from one's mental processes or body (depersonalization), or experiences of unreality or detachment from one's surroundings (derealization), as if one is an outside observer. The primary symptom here is not detachment but rather a loss of personal identity and memory. - Patients with depersonalization/derealization disorder typically maintain a sense of personal identity and recall their past, which is contrary to the details of this case. *Korsakoff syndrome* - This is a neurological disorder caused by a severe deficiency of **thiamine (vitamin B1)**, often associated with chronic alcohol abuse, leading to severe anterograde and retrograde amnesia, confabulation, and often ataxia and ophthalmoplegia. While the patient drinks, her vital signs and neurological exam are normal, and her acute presentation isn't typical for Korsakoff. - The primary type of memory loss in Korsakoff is generally chronic and global, particularly affecting the ability to form new memories (**anterograde amnesia**), whereas this patient's short-term memory is noted as intact, and the amnesia is specific to personal identity. *Delirium* - Delirium is characterized by an acute, fluctuating disturbance in attention and awareness, along with cognitive changes that develop over a short period. This patient's vital signs are stable, and she lacks the global cognitive disorganization often seen in delirium. - The absence of a clear medical cause, intoxicant, or withdrawal, along with her ability to be oriented to time and place (albeit not person), makes delirium less likely.
Explanation: ***Correct: Reaction formation*** - **Reaction formation** involves unconsciously replacing an unacceptable feeling or urge with its directly opposing, more acceptable counterpart. - The patient's vehement preaching against alcohol (opposite of his secret drinking) is a classic example of this defense mechanism. - This defense allows him to manage the anxiety from his unacceptable impulse by adopting an extreme opposite public stance. *Incorrect: Acting out* - **Acting out** is the expression of an unconscious emotional conflict or impulse through action, often destructive or inappropriate behaviors. - While his drinking could be considered acting out, the key feature of this case is his public preaching against the very behavior he engages in privately, which is more specific to reaction formation. *Incorrect: Projection* - **Projection** is attributing one's own unacceptable thoughts, feelings, or impulses to another person. - The patient is not attributing his drinking problem to others; he is actively opposing it publicly while engaging in it privately. *Incorrect: Rationalization* - **Rationalization** is concocting a seemingly logical reason or excuse for an unacceptable behavior or impulse. - The patient is not trying to explain away his drinking; rather, he is defending against the impulse by adopting an extreme opposing stance. *Incorrect: Displacement* - **Displacement** is redirecting one's feelings (often hostility or anger) from the original target to a less threatening substitute. - There is no evidence of him redirecting emotions from one target to another in this scenario.
Explanation: ***Panic attack*** - The sudden onset of **severe dyspnea** and **dizziness** in a distressed patient, along with ABG results indicating **respiratory alkalosis** (pH 7.51, pCO2 30 mm Hg), is highly characteristic of a panic attack with hyperventilation. - **Hyperventilation** leads to excessive CO2 exhalation, causing the pCO2 to drop and the pH to rise, resulting in symptoms like lightheadedness and dyspnea. *Myasthenia gravis* - This is a **neuromuscular disorder** causing muscle weakness, which can lead to respiratory compromise over time, but typically does not present with such acute, sudden dyspnea and dizziness without prior symptoms. - The ABG findings of respiratory alkalosis are not typical for a primary myasthenic crisis, which would likely show respiratory acidosis if respiratory failure were imminent. *Opioid toxicity* - Opioid overdose causes **respiratory depression**, leading to reduced respiratory rate and shallow breathing, which would result in **respiratory acidosis** (increased pCO2 and decreased pH), not alkalosis. - The patient's pO2 of 100 mm Hg also argues against significant respiratory depression. *Epiglottitis* - Epiglottitis presents with a **rapidly worsening sore throat**, difficulty swallowing, drooling, and stridor, indicating upper airway obstruction. - While it causes severe dyspnea, the ABG would likely show signs of hypoxemia and potentially acidosis due to airway compromise, not hyperventilation-induced alkalosis. *Pulmonary fibrosis* - This is a **chronic interstitial lung disease** that causes progressive dyspnea, often with a dry cough. - The onset of symptoms is typically gradual, over months to years, not sudden within 30 minutes, and ABG would likely show hypoxemia with compensated respiratory alkalosis or acidosis depending on the stage, but not acutely severe hyperventilation-induced alkalosis.
Explanation: ***Cognitive behavioral therapy and fluoxetine*** - This patient presents with symptoms highly suggestive of **obsessive-compulsive disorder (OCD)**, characterized by intrusive, distressing thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) performed to neutralize the anxiety. - **Cognitive Behavioral Therapy (CBT)**, specifically Exposure and Response Prevention (ERP), is the most effective psychotherapy for OCD, and **SSRIs** like fluoxetine are the first-line pharmacotherapy. *Psychodynamic psychotherapy and citalopram* - While citalopram (an SSRI) is an appropriate pharmacological treatment for OCD, **psychodynamic psychotherapy** is generally not considered first-line or most effective for OCD due to its focus on unconscious conflicts rather than direct symptom reduction. - This approach may not provide the structured, symptom-focused interventions needed to manage obsessions and compulsions effectively. *Cognitive behavioral therapy and haloperidol* - **CBT** is an excellent choice, but **haloperidol**, an antipsychotic, is not a first-line treatment for OCD; it is primarily used for psychotic disorders or as an augmentation strategy in severe, treatment-resistant OCD, which is not indicated here. - Using an antipsychotic as a primary treatment for OCD without a clear indication of psychosis or severe non-response to SSRIs is inappropriate and can lead to unnecessary side effects. *Cognitive behavioral therapy and clonazepam* - **CBT** is appropriate, but **clonazepam**, a benzodiazepine, is generally not recommended as a monotherapy or primary adjunctive treatment for OCD due to its *sedative side effects*, *potential for dependence*, and *lack of efficacy* in addressing the core symptoms of OCD. - Benzodiazepines may be used for short-term anxiety relief but do not treat the underlying obsessive-compulsive processes. *Psychodynamic psychotherapy and aripiprazole* - **Psychodynamic psychotherapy** is not the most effective approach for OCD. - **Aripiprazole**, an atypical antipsychotic, is typically used as an augmentation strategy for *treatment-resistant OCD* when initial SSRI trials have failed, not as a first-line medication, and this patient's case does not describe treatment resistance.
Explanation: ***Referring the patient for confirmation of sexual abuse*** - The patient's statements about the "new art teacher touching her inappropriately," coupled with a sudden shift in behavior including withdrawal, anger, hostility, and truancy, are **red flags for potential sexual abuse**. - As a mandatory reporter, the physician has a legal and ethical obligation to investigate these allegations and ensure the child's safety, making a referral for confirmation of abuse the most critical immediate step. *Prescribing oral contraceptive pills* - There is **no indication** for contraception in this scenario, as the primary concern is potential abuse, not a request for birth control. - Addressing the underlying behavioral and safety concerns takes precedence over prescribing medication for which there is no demonstrated need. *Performing a thorough genitourinary exam* - While a genitourinary exam might be part of an abuse investigation, it should be performed by a specialist in a **child-friendly, trauma-informed setting** and only after the appropriate referral and assessment for abuse has been initiated. - Performing it as the *first* step without proper context or preparation could further traumatize the child. *Obtaining STD screening* - Similar to the genitourinary exam, STD screening is a component of a comprehensive sexual abuse evaluation but should not be the **initial or primary step**. - It would follow a referral and confirmed suspicion of abuse, and be part of a coordinated care plan. *Referring the patient and her parents for family therapy* - While family therapy may be beneficial in addressing the impact of the parents' divorce or behavioral issues, it is **not the immediate priority** when there are direct allegations and strong indicators of sexual abuse. - The safety of the child must be ensured first, and family therapy may not be appropriate in an acute abuse situation without prior investigation.
Explanation: ***Transference*** - **Transference** is when a patient unconsciously redirects emotions and feelings from a significant person in their past (e.g., a deceased husband) onto their therapist in the therapeutic relationship. - The widow's feelings of affection and warmth toward her therapist, derived from his resemblance to her deceased husband, are a classic example of transference in psychotherapy. - Transference is a normal part of the therapeutic process and provides important material for therapeutic work. *Sublimation* - **Sublimation** is a mature defense mechanism where unacceptable urges or feelings are unconsciously channeled into socially acceptable behaviors. - This scenario does not involve redirecting inappropriate desires into constructive activities. *Projection* - **Projection** is an ego defense mechanism in which an individual attributes their own unacceptable thoughts, feelings, or impulses to another person. - The scenario describes the patient experiencing feelings herself, not attributing her own feelings to the therapist. *Countertransference* - **Countertransference** refers to the therapist's unconscious emotional reactions to a patient, often in response to the patient's transference. - This concept applies to the therapist's feelings toward the patient, not the patient's feelings toward the therapist. *Identification* - **Identification** is a defense mechanism where an individual unconsciously takes on the characteristics, behaviors, or attitudes of another person. - The patient is not adopting the therapist's characteristics but rather experiencing feelings toward him based on her past relationship with her husband.
Explanation: ***Conversion disorder*** - The sudden onset of blindness following significant stress (relationship problems) and the absence of any physiological explanation (normal ophthalmological exam, MRI, vital signs) are classic features of **conversion disorder**. - **La belle indifference**, or a lack of concern about the dramatic symptom, may be present, though anxiety can also be observed. The nonspecific visual field defects further support a non-organic cause. *Somatic symptom disorder* - This disorder involves having **one or more somatic symptoms that are distressing or result in significant disruption of daily life**, accompanied by excessive thoughts, feelings, or behaviors related to those symptoms. - Unlike conversion disorder, somatic symptom disorder typically involves a **persistent preoccupation** with the physical symptoms and associated anxieties, rather than a single dramatic neurological symptom with no medical explanation. *Factitious disorder* - In **factitious disorder**, individuals **intentionally produce or feign physical or psychological signs or symptoms** for the primary purpose of assuming the sick role. - The key differentiator is the **conscious production of symptoms** without external incentives, which is not suggested by the patient's presentation here, especially the sudden blindness in response to stress. *Malingering* - **Malingering** involves the **intentional production of false or grossly exaggerated physical or psychological symptoms** motivated by **external incentives**, such as avoiding work, obtaining financial compensation, or evading criminal prosecution. - The patient's presentation does not suggest any obvious external incentives for feigning blindness. *Retinal detachment* - **Retinal detachment** would typically present with symptoms such as **flashing lights (photopsia), floaters, or a curtain-like visual field defect**. - A retinal detachment would be readily identifiable on **fundoscopic examination**, which was reported as normal in this patient.
Explanation: ***Obsessive-compulsive disorder*** - The patient exhibits **recurrent, persistent thoughts (obsessions)** about his dorm room burning down and **repetitive behaviors (compulsions)** of checking appliances, which are characteristic of OCD. - These obsessions and compulsions cause **significant distress** and **impairment** in his social activities and academic life, meeting the diagnostic criteria for OCD. *Tourette syndrome* - This condition is primarily characterized by **multiple motor tics** and **one or more vocal tics**, which fluctuate over time. - While tics can be severe and impairing, they are distinct from the **obsessive thoughts** and **compulsive checking behaviors** described in the patient. *Delusional disorder* - Delusional disorder involves the presence of **non-bizarre delusions** (beliefs that are not obviously implausible) for at least one month, without other significant psychotic symptoms. - The patient's preoccupation with his dorm room burning down, while intense, is recognized by him as excessive ("he knows he already checked everything thoroughly"), indicating it is an obsession rather than a **firmly held false belief (delusion)**. *Schizophrenia* - Schizophrenia is characterized by a combination of positive symptoms (e.g., **hallucinations, delusions, disorganized speech**), negative symptoms (e.g., **alogia, avolition**), and cognitive dysfunction. - The patient's symptoms are specific to obsessions and compulsions, without the broader range of **psychotic symptoms** or **functional decline** typically seen in schizophrenia. *Obsessive-compulsive personality disorder* - OCPD is a pervasive pattern of preoccupation with **orderliness, perfectionism**, and **mental and interpersonal control** at the expense of flexibility, openness, and efficiency. - Unlike OCD, OCPD does not involve true **obsessions** or **compulsions** and is considered ego-syntonic, meaning the individual perceives their traits as desirable, whereas the patient is distressed by his checking behavior.
Explanation: ***Prazosin therapy*** - **Prazosin**, an alpha-1 adrenergic antagonist, is effective in reducing **nightmares and sleep disturbances** associated with **post-traumatic stress disorder (PTSD)**, especially when SSRIs are insufficient. - It works by blocking the effects of norepinephrine, thereby reducing hyperarousal and improving sleep quality in patients with PTSD. *Triazolam therapy* - **Triazolam** is a short-acting benzodiazepine primarily used for **insomnia** but is generally not recommended for long-term use due to its potential for **dependence** and withdrawal symptoms. - While it can help with sleep onset, it does not address the underlying **PTSD-related nightmares** and may worsen the overall sleep architecture. *Diazepam therapy* - **Diazepam** is a long-acting benzodiazepine that can provide sedation, but its use in PTSD is **limited due to risks of dependence**, sedation, and cognitive impairment. - Benzodiazepines like diazepam can also **suppress REM sleep**, which is where nightmares occur, but they don't treat the root cause of the nightmares and are not a first-line therapy for PTSD sleep disturbances. *Supportive psychotherapy* - While **psychotherapy is crucial for PTSD**, the patient has already refused **cognitive behavioral therapy (CBT)**, and supportive psychotherapy, while helpful, may not specifically target persistent **nightmares** as effectively as targeted pharmacological interventions when initial SSRI treatment has failed. - Other forms of psychotherapy like **trauma-focused CBT** or **eye movement desensitization and reprocessing (EMDR)** would be more appropriate for PTSD, but the question asks for the next **management step** for persistent nightmares after an SSRI. *Phenelzine therapy* - **Phenelzine** is a **monoamine oxidase inhibitor (MAOI)**, an older class of antidepressants with a **significant side effect profile** and numerous dietary restrictions due to risk of **hypertensive crisis**. - While MAOIs can be used in refractory depression or anxiety, they are **not a first-line treatment for PTSD** and their risks typically outweigh benefits for sleep disturbances in this context, especially given safer and more targeted options.
Explanation: ***Post-traumatic stress disorder*** - The patient experienced a **traumatic event** (witnessing a fatal accident) and now exhibits characteristic symptoms occurring more than one month after the trauma. - **Re-experiencing symptoms**: Panicking during car crash scenes on TV or when passing accidents (intrusive trauma-related memories triggered by reminders). - **Avoidance**: Social withdrawal may represent avoiding situations or activities related to the trauma. - **Negative alterations in cognition and mood**: Guilt about the girl's death ("could have saved her"), depressed moods. - **Arousal and reactivity symptoms**: Irritability, heightened anxiety, exaggerated startle response (panic when exposed to trauma cues). - These symptoms have persisted for **longer than one month**, distinguishing it from acute stress disorder, and significantly impact his social functioning. *Panic disorder* - Characterized by recurrent, unexpected **panic attacks** (not triggered by specific cues) and persistent worry about future attacks or their consequences. - While the patient experiences panic, it is specifically triggered by **trauma-related cues** (car accidents), not spontaneous attacks, which points to PTSD rather than panic disorder. *Generalized anxiety disorder* - Involves excessive and uncontrollable worry about various events or activities, present for **at least six months**. - The patient's anxiety is clearly linked to a **specific trauma** and has specific triggers (car accidents), rather than the broad, pervasive worry characteristic of GAD. *Adjustment disorder* - Symptoms develop in response to an identifiable stressor but are **less severe** than PTSD and do not meet criteria for another mental disorder. - The patient's symptoms include specific PTSD features (re-experiencing, trauma-specific triggers, persistent guilt) that exceed adjustment disorder severity. - Symptoms typically resolve within **six months** of stressor termination; PTSD symptoms are more persistent. *Acute stress disorder* - Characterized by symptoms similar to PTSD (intrusion, avoidance, negative mood, arousal), but they occur within **three days to one month** of the traumatic event. - The patient's symptoms are reported to be present **one month later** with persistence beyond the one-month mark, thus meeting criteria for PTSD rather than acute stress disorder.
Explanation: **Cognitive-behavioral therapy** - **Cognitive-behavioral therapy (CBT)**, specifically **Exposure and Response Prevention (ERP)**, is the most effective psychotherapy for **obsessive-compulsive disorder (OCD)**, which this patient's symptoms strongly suggest. - CBT helps patients challenge distorted thoughts and gradually expose themselves to feared situations while preventing compulsive rituals, thus breaking the cycle of obsessions and compulsions. *Psychodynamic psychotherapy* - This therapy focuses on **unconscious conflicts** and **past experiences** to understand current symptoms. - While it can be helpful for some mental health conditions, it is generally **less effective** than CBT for the specific, highly ritualized symptoms of OCD. *Motivational interviewing* - **Motivational interviewing** is a patient-centered counseling style designed to address **ambivalence about change** and enhance intrinsic motivation. - It is often used in substance abuse or lifestyle changes, but it does not directly teach coping skills for OCD symptoms or address the underlying thought patterns. *Interpersonal therapy* - **Interpersonal therapy (IPT)** focuses on the patient's **current interpersonal relationships** and social functioning. - While social difficulties can arise from OCD, IPT does not directly target the obsessions and compulsions that are central to the disorder. *Group therapy* - **Group therapy** can provide support and a sense of community, but for a severe condition like OCD, **individual therapy** (especially CBT/ERP) is typically recommended first due to the highly individualized nature of obsessions and compulsions. - It may be a complementary approach, but usually not the most appropriate initial next step given the intensity of the patient's symptoms.
Explanation: ***Tourette's syndrome*** - This patient's symptoms of **obsessive handwashing** due to a fear of germs and significant distress if not performed are classic for **Obsessive-Compulsive Disorder (OCD)**. - **Tourette's syndrome** is commonly comorbid with **OCD**, with up to 60% of individuals with Tourette's also having OCD. *Autism spectrum disorders* - While individuals with **autism spectrum disorders** may exhibit **repetitive behaviors** or rituals, these are typically distinct from the intrusive thoughts and anxiety-driven compulsions of OCD. - The core features of autism involve impairments in **social communication** and interaction, which are not described as the primary issue here. *Delusional disorder* - **Delusional disorder** involves **fixed, false beliefs** that are not amenable to change in light of conflicting evidence, and these delusions are usually non-bizarre. - The patient's belief about germs, while intense, is recognized as a source of anxiety by him and doesn't reach the level of a fixed, false delusion. *Rett's disorder* - **Rett's disorder** is a neurodevelopmental disorder almost exclusively affecting **females**, characterized by normal early development followed by regression in social and communication skills, and characteristic **stereotypic hand movements**. - The patient is male, and the presentation of OCD symptoms does not align with the typical progression of Rett's disorder. *Obsessive-compulsive personality disorder* - **Obsessive-compulsive personality disorder (OCPD)** is characterized by a pervasive pattern of **preoccupation with orderliness, perfectionism**, and mental and interpersonal control, at the expense of flexibility, openness, and efficiency. - Unlike **OCD**, OCPD generally does not involve true obsessions or compulsions but rather ego-syntonic traits that the individual sees as desirable.
Explanation: ***Delta waves*** - The child's symptoms (screaming, thrashing, unresponsiveness during waking, confusion afterward, and no recall) are characteristic of **sleep terror (pavor nocturnus)**, which is a **non-REM parasomnia**. - Sleep terrors typically occur during **slow-wave sleep (NREM stage 3/4 sleep)**, which is predominantly characterized by the presence of **delta waves** on an EEG. *Theta waves* - **Theta waves** are characteristic of **NREM stage 1 and 2 sleep**, which are lighter stages of sleep. - Sleep terrors are arousal disorders that originate from the deep stages of non-REM sleep, not the lighter stages where theta waves are prominent. *Sleep spindles* - **Sleep spindles** and **K-complexes** are characteristic EEG findings of **NREM stage 2 sleep**. - While stage 2 is part of NREM sleep, sleep terrors are specifically associated with the deeper NREM stage 3/4, which is dominated by delta waves, not sleep spindles. *Beta waves* - **Beta waves** are high-frequency, low-amplitude waves associated with **awake, alert, and active mental states**. - Their presence indicates wakefulness or active mental engagement and is not associated with any stage of sleep. *Alpha waves* - **Alpha waves** are characteristic of a state of **relaxed wakefulness**, often with closed eyes, and are a precursor to sleep onset. - They are not associated with the deep sleep stages where sleep terrors occur.
Explanation: ***Oral alprazolam*** - This patient is experiencing an acute panic attack, characterized by sudden onset of intense fear, physical symptoms (palpitations, sweating, shortness of breath), and a fear of losing control or dying. **Benzodiazepines like alprazolam** are the most appropriate initial treatment for rapid symptom relief due to their fast onset of action. - The patient's history of recurrent, uncued episodes, fear of future attacks, and subsequent avoidance behaviors (staying at home) are consistent with a diagnosis of **panic disorder**. *Oral propranolol* - **Beta-blockers like propranolol** can help manage some physical symptoms of anxiety (e.g., palpitations, tremor) by blocking adrenergic receptors. However, they are not effective in directly reducing the psychological distress or fear associated with acute panic attacks. - Propranolol might be considered for **performance anxiety** or generalized anxiety with prominent physical symptoms but is not first-line for acute panic. *Oral venlafaxine* - **Venlafaxine**, a serotonin-norepinephrine reuptake inhibitor (SNRI), is a first-line treatment for **panic disorder** for long-term management and prevention of future attacks. - However, its onset of action is slow (several weeks), making it unsuitable for immediate relief during an **acute panic attack**. *Oral buspirone* - **Buspirone** is an anxiolytic that is used for generalized anxiety disorder. It has a slow onset of action and is less effective for acute panic attacks. - It does not provide the rapid, potent anxiolytic effects needed for an urgent presentation of **panic symptoms**. *Long-term ECG monitoring* - While an **ECG is appropriate during an acute presentation** to rule out cardiac causes, and the current ECG shows only sinus tachycardia, long-term ambulatory ECG monitoring (Holter monitor) is not the initial step for managing an acute panic attack in the absence of other cardiac symptoms or pathology. - The patient's symptoms are highly suggestive of a **psychiatric condition (panic attack)**, and cardiac causes have already been largely ruled out by the initial ECG and unremarkable cardiopulmonary exam.
Explanation: ***Separation anxiety disorder*** - This child exhibits classic symptoms of **separation anxiety disorder**, including **school refusal** due to physical complaints (abdominal pain), **difficulty sleeping alone**, and **excessive distress** when separated from a primary attachment figure (mother). - The symptoms started shortly after attending a new school, a common trigger for separation anxiety, and have persisted for 6 months, meeting the **diagnostic criteria for duration** in children (≥4 weeks). *Acute stress disorder* - **Acute stress disorder** typically occurs within one month of exposure to a **traumatic event** and involves symptoms like intrusive thoughts, negative mood, dissociation, and hypervigilance. - The boy's symptoms are **chronic (6 months)** and are related to separation, not a specific traumatic event, making this diagnosis less likely. *Normal behavior* - While some mild separation anxiety is normal in young children, the **severity**, **duration (6 months)**, and **functional impairment** (missing school, difficulty sleeping alone) in this 7-year-old go beyond what is considered typical developmental behavior. - Normal separation anxiety usually resolves by preschool age or is short-lived without significant impact on daily life. *Irritable bowel syndrome* - **Irritable bowel syndrome (IBS)** is a common cause of recurrent abdominal pain, but it is typically associated with **changes in bowel habits** (constipation or diarrhea), which are absent in this case. - Furthermore, the child's other symptoms, such as **school refusal**, **sleep disturbances**, and **distress upon separation**, are not characteristic of IBS and point towards a psychological rather than purely gastrointestinal etiology. *Conduct disorder* - **Conduct disorder** involves a persistent pattern of **aggressive behavior**, **destruction of property**, **deceitfulness or theft**, and **serious rule violations**, none of which are described in this case. - The child's symptoms are characterized by anxiety and emotional distress related to separation, not defiant or antisocial behavior.
Explanation: ***Reassurance*** - The patient exhibits symptoms of **"baby blues"**, including tearfulness, anxiety, mood swings, and feeling overwhelmed, which are common within the first two weeks postpartum and typically resolve spontaneously. - Given the transient nature of **baby blues** and the absence of more severe symptoms like psychosis or significant functional impairment, **reassurance** and supportive care are the most appropriate initial steps. *Risperidone therapy* - **Risperidone** is an **antipsychotic** medication used for conditions like psychosis or severe mood disorders, which are not present in this patient's mild, transient symptoms of baby blues. - Initiating antipsychotic therapy for **self-limiting baby blues** is unnecessary and could lead to unwanted side effects. *Bupropion therapy* - **Bupropion** is an **antidepressant** primarily used for major depressive disorder and seasonal affective disorder, and is not indicated for the mild, transient symptoms of **baby blues**. - Its mechanism of action involves dopamine and norepinephrine reuptake inhibition, differing from typical SSRIs often considered for postpartum depression. *Cognitive behavioral therapy* - While **CBT** is an effective treatment for **postpartum depression** and anxiety disorders, the patient's symptoms are consistent with **baby blues**, which are self-limiting and resolve with supportive care in most cases. - CBT would be more appropriate if the symptoms were severe, persistent beyond two weeks, or indicative of a more significant mood disorder. *Sertraline therapy* - **Sertraline** is an **SSRI antidepressant** commonly used for **postpartum depression** and anxiety, but it is not indicated for the transient and mild symptoms of **baby blues**. - Antidepressants are typically reserved for more severe and persistent symptoms characteristic of postpartum depression, which usually lasts longer than two weeks.
Explanation: ***Obsessive compulsive disorder (OCD)*** - The patient's **recurrent distressing thoughts** about dirtiness (obsessions) and **repetitive cleaning behaviors** (compulsions) designed to reduce anxiety are hallmark symptoms of OCD. - The significant **emotional distress**, impact on daily life, and worsening stress despite the compulsions further support this diagnosis. *Panic Disorder (PD)* - Characterized by **recurrent, unexpected panic attacks** and persistent worry about additional attacks or their consequences. - While anxiety is present, the patient's primary distress is driven by specific obsessions and compulsions, not sudden episodes of intense fear. *Generalized anxiety disorder (GAD)* - Involves **excessive, uncontrollable worry** about a variety of events or activities for at least 6 months. - The anxiety symptoms are general, not focused on specific obsessions leading to compulsive behaviors as seen in this case. *Obsessive compulsive personality disorder (OCPD)* - Marked by pervasive patterns of **perfectionism, orderliness, and control** at the expense of flexibility and efficiency. - While there may be a preoccupation with rules, OCPD does not typically involve intrusive, ego-dystonic obsessions or ritualistic compulsions like repetitive cleaning to reduce anxiety. *Tic disorder* - Characterized by **sudden, rapid, recurrent, non-rhythmic motor movements or vocalizations**. - Tics are distinct from the complex, goal-directed, and anxiety-driven compulsive behaviors described by the patient.
Explanation: ***Acute stress disorder*** - The patient experiences **intrusive memories** (nightmares), **avoidance** (of her car), **negative mood** (depressed mood, negative affect), **dissociative symptoms** (difficulty concentrating, feeling dazed), and **arousal symptoms** (difficulty sleeping, palpitations, profuse sweating, irritability) within **one month of a traumatic event** (sexual assault). - These symptoms cause **significant distress** and **functional impairment**, meeting the diagnostic criteria for acute stress disorder. *Post-traumatic stress disorder* - This diagnosis is considered if the symptoms persist for **longer than one month** after the traumatic event. - While the patient exhibits many PTSD symptoms, the **timeline** (three weeks since the assault) fits acute stress disorder more precisely. *Persistent complex bereavement disorder* - This disorder is diagnosed in response to the **death of a loved one** where grief symptoms are unusually prolonged and impairing. - The patient's symptoms are a direct result of a **sexual assault**, not the death of a loved one. *Adjustment disorder* - Adjustment disorder involves emotional or behavioral symptoms in response to an **identifiable stressor**, but the symptoms are **less severe** and do not meet the full criteria for other specific mental disorders. - The patient's symptoms are extensive, debilitating, and clearly meet criteria for a more specific stress-related disorder. *Adverse effect of medication* - While some medications can cause sleep disturbances or mood changes, the patient's symptoms are directly tied to a **recent traumatic event** and include classic features of a stress-related disorder. - Her current medication, **levothyroxine**, is unlikely to cause a sudden onset of such a complex constellation of symptoms, especially avoidance behaviors and flashbacks.
Explanation: ***Buspirone*** - **Buspirone** is a non-benzodiazepine anxiolytic agent. It is often preferred for long-term management of **generalized anxiety disorder (GAD)** due to its favorable side effect profile and lack of dependence potential, addressing the patient's chronic symptoms effectively. - Unlike benzodiazepines, buspirone does not cause sedation or withdrawal symptoms, making it suitable for a patient experiencing prolonged anxiety, sleep disturbances, and irritability. *Support groups* - While **support groups** can provide emotional support and coping strategies, they are typically used as an adjunct to pharmacotherapy or psychotherapy, not as a primary standalone treatment for moderate to severe GAD. - This patient's symptoms (lethargy, significant muscle tension, chronic worrying, sleep disturbance) suggest a need for a more direct pharmacological intervention to alleviate her symptoms. *A vacation* - A vacation might offer temporary relief from stress but will not address the underlying physiological and psychological components of her **generalized anxiety disorder**. - Her chronic and pervasive worrying, along with physical symptoms, indicates a need for sustained medical management. *Diazepam* - **Diazepam** is a benzodiazepine that provides rapid, short-term relief from anxiety, but it is generally not recommended for long-term management due to the risks of **dependence, tolerance, and withdrawal symptoms**, especially in a patient with chronic symptoms. - Given the patient's 6-month history of symptoms, a medication with a better long-term safety profile is preferred. *Family therapy* - **Family therapy** could be beneficial if family dynamics are a significant contributor to her stress or if her symptoms are impacting family relationships negatively. However, it does not directly address the primary diagnosis of generalized anxiety disorder with its constellation of chronic symptoms. - While it may provide some support, it is not the initial best course of treatment for the patient's core anxiety symptoms.
Explanation: ***Agoraphobia*** - The patient's avoidance of leaving the house alone due to fear of symptom recurrence in various situations (e.g., walking, waiting in line), and her reliance on her boyfriend's presence, are classic symptoms of **agoraphobia**. - Agoraphobia typically involves marked fear or anxiety about being in situations from which escape might be difficult or embarrassing, or in which help might not be available in the event of panic-like symptoms. - The key feature here is the **pervasive avoidance behavior** that significantly restricts her independence and daily functioning. *Separation anxiety disorder* - This disorder is characterized by excessive anxiety concerning separation from home or from those to whom the individual is attached. - While the patient avoids leaving home, her anxiety is not specifically about separating from an attachment figure, but rather about being alone when panic-like symptoms might occur in situations where escape or help is unavailable. *Generalized anxiety disorder* - Generalized anxiety disorder involves persistent and excessive worry about multiple everyday events or activities for at least six months. - The patient's symptoms are episodic and specifically triggered by certain situations with agoraphobic features, rather than a constant, diffuse worry about various life circumstances. *Panic disorder* - Panic disorder is characterized by recurrent, unexpected panic attacks and persistent worry about additional attacks or their consequences. - While the patient clearly experiences panic attacks, panic disorder alone does not fully explain the **extensive avoidance behavior** and dependence on a companion for routine activities. - In DSM-5, agoraphobia and panic disorder can co-occur, but when the predominant clinical feature is the situational avoidance and restriction of independence (as seen here), agoraphobia is the more complete diagnosis. *Somatic symptom disorder* - This disorder involves one or more somatic symptoms that are distressing or result in significant disruption of daily life, accompanied by excessive thoughts, feelings, or behaviors related to the symptoms. - Although the patient's physical symptoms are distressing, the primary issue is the fear and avoidance of specific situations where help might not be available, not a preoccupation with the somatic symptoms themselves or excessive healthcare utilization.
Explanation: ***Alprazolam*** - This patient is experiencing an **acute panic attack**, and **benzodiazepines** like alprazolam are the **treatment of choice for immediate symptom relief** due to their rapid anxiolytic effects. - The patient's symptoms (squeezing chest pain, racing heart, worry about heart attack, tachypnea, fidgetiness, normal ECG except for sinus tachycardia) are classic for a panic attack. - For **acute management**, benzodiazepines work within minutes, though SSRIs would be initiated concurrently for **long-term management** of panic disorder. *Buspirone* - Buspirone is an **anxiolytic** but has a **delayed onset of action** (weeks to take effect), making it unsuitable for acute panic attacks. - It is typically used for **generalized anxiety disorder** for long-term management, not for immediate symptom resolution. *Propranolol* - Propranolol is a **beta-blocker** that can help reduce the **physical symptoms of anxiety** (e.g., palpitations, tremor) but does not address the underlying psychological component of panic. - It is not considered first-line for acute panic attacks, especially when benzodiazepines are more effective for rapid relief of both physical and psychological symptoms. *Sertraline* - Sertraline is an **SSRI** used for **long-term management of panic disorder** and is the preferred maintenance therapy. - Its therapeutic effects take **several weeks to manifest**, making it inappropriate for immediate symptom relief in an acute attack. - While SSRIs should be initiated for ongoing treatment, they do not address the current acute episode. *Nitroglycerin* - Nitroglycerin is used to treat **angina (chest pain due to myocardial ischemia)** and acts by vasodilation. - The patient's symptoms are inconsistent with angina (young age, unremarkable family history, normal ECG, recurrent self-limited episodes, and features suggesting panic disorder), and there is no indication of cardiac ischemia.
Explanation: ***Post-traumatic stress disorder*** - The patient's symptoms, including **nightmares** about another heart attack, **hypervigilance** (being jumpy and easily startled), **avoidance behaviors** (strenuous activities, bar), **detachment**, and feelings of **hopelessness**, are characteristic of **PTSD** following a traumatic event like a myocardial infarction. - The symptoms have persisted for **6 weeks**, exceeding the 1-month duration required for a PTSD diagnosis. *Major depressive disorder* - While feelings of **hopelessness** and **detachment** are present, the pervasive **recurrent nightmares**, **hypervigilance**, and **avoidance specifically related to the traumatic event** (MI) point more strongly to PTSD. - A diagnosis of MDD would not fully encompass the trauma-specific symptoms described. *Acute stress disorder* - This diagnosis is considered when symptoms similar to PTSD (intrusion, negative mood, dissociation, avoidance, arousal) occur within **3 days to 1 month** after a traumatic event. - Since the patient's symptoms have been ongoing for **6 weeks**, exceeding the 1-month timeframe, acute stress disorder is ruled out. *Alcohol withdrawal* - Symptoms of alcohol withdrawal typically include **tremors, hallucinations, seizures, and delirium**, often developing rapidly after a reduction in alcohol intake. - The patient's symptoms of **nightmares related to his MI**, **hypervigilance**, and emotional detachment are not characteristic of alcohol withdrawal. *Midlife crisis* - This is a non-clinical term describing a period of **emotional turmoil and self-doubt** that may occur in middle age, often involving questioning life choices and goals. - While the patient is in midlife, his specific symptom constellation, particularly the trauma-related nightmares and hypervigilance, aligns with a diagnosable mental health condition rather than a general life transition.
Explanation: ***Submissive, clingy, and low self-confidence*** - The patient's symptoms are highly suggestive of **panic disorder** with **agoraphobia**. Panic disorder is genetically correlated with **Cluster C (anxious) personality disorders**, particularly **dependent personality disorder** and **avoidant personality disorder**. - These personality disorders share genetic vulnerability factors with anxiety disorders including panic disorder, involving neurotransmitter systems (serotonin, GABA) and temperamental traits related to anxiety sensitivity and behavioral inhibition. - Dependent personality disorder features include **submissiveness, excessive need to be cared for, clinging behavior, and low self-confidence** - all reflecting the underlying anxious temperament shared with panic disorder. *Social withdrawal and limited emotional expression* - These features describe **schizoid personality disorder** (Cluster A), which is characterized by social detachment and restricted emotional range. - Schizoid personality disorder is NOT genetically associated with panic disorder. It belongs to the odd/eccentric cluster and has different genetic underpinnings related to the schizophrenia spectrum. *Grandiosity, entitlement, and need for admiration* - These features are characteristic of **narcissistic personality disorder** (Cluster B), which has no established genetic association with panic disorder. - Narcissistic personality disorder is part of the dramatic/erratic cluster and involves different personality pathology unrelated to anxiety disorders. *Criminality and disregard for rights of others* - These features describe **antisocial personality disorder** (Cluster B), which is not genetically linked to panic disorder. - Antisocial personality disorder is associated with conduct disorder and involves impulsivity and aggression rather than anxiety-related traits. *Eccentric appearance and magical thinking* - These are features of **schizotypal personality disorder** (Cluster A), which is genetically associated with the **schizophrenia spectrum**, not panic disorder. - Schizotypal individuals display cognitive-perceptual distortions and odd behaviors that are unrelated to anxiety disorder genetics.
Explanation: ***Generalized anxiety disorder*** - This patient exhibits **excessive anxiety and worry** about multiple life domains (school performance, relationship, health) that is **difficult to control** and present for an extended period, which are key features of GAD. - Associated symptoms like **sleep disturbance**, feeling **on edge**, and **difficulty concentrating** further support this diagnosis. *Acute stress disorder* - This disorder occurs **within 1 month of exposure to a traumatic event** and involves dissociative symptoms, intrusive thoughts, and hyperarousal. - While the patient is re-experiencing his grandfather's funeral, the duration of symptoms and the broad range of worries extend beyond the typical presentation and time frame of acute stress disorder. *Depression* - Although the patient shows signs of **low self-worth** ("terrible person") and **guilt**, these are intertwined with his anxieties about various life stressors. - The primary and pervasive symptom is **worry** rather than the sustained anhedonia or profound sadness characteristic of a major depressive episode. *Obsessive compulsive disorder* - This disorder is characterized by **recurrent, intrusive thoughts (obsessions)** and **repetitive behaviors or mental acts (compulsions)** aimed at reducing anxiety. - While the patient's praying every 4 hours could be seen as a ritualistic behavior, it's not clearly linked to specific, intrusive obsessions, and the predominant symptoms are **worry about multiple life domains**, not ritualistic behavior driven by obsessions. *Post traumatic stress disorder* - This disorder requires exposure to a **traumatic event** and persistent symptoms for **more than 1 month**, including re-experiencing, avoidance, negative alterations in cognitions and mood, and hyperarousal. - While the patient re-experiences the funeral of his grandfather, his primary concerns and symptoms revolve around **generalized worries** rather than the pervasive avoidance and hyperarousal typically seen with PTSD.
Explanation: ***Somatic symptom disorder*** - This patient exhibits **multiple somatic symptoms** (abdominal pain, inconsistent bowel habits, fear of incarcerated hernia), along with excessive thoughts, feelings, and behaviors related to these symptoms, causing significant distress and functional impairment. - Her persistent worry about the incarcerated hernia despite reassurance, and frequent clinic visits for unrelated physical complaints without identifiable etiology, align with the diagnostic criteria for **somatic symptom disorder**. *Illness anxiety disorder* - Characterized by a preoccupation with having or acquiring a serious illness, but with **minimal or no somatic symptoms** present. - In this case, the patient clearly has actual physical symptoms (abdominal pain, inconsistent bowel habits, and the inguinal swelling itself), differentiating it from illness anxiety disorder where the primary concern is the *fear* of illness rather than the experience of symptoms. *Conversion disorder* - Involves neurological symptoms (e.g., paralysis, blindness, seizures) that are **incompatible with recognized neurological conditions** and are not intentionally produced. - The patient's symptoms are primarily somatic and not neurological, and she is worried about an *existing* medical issue (hernia) rather than developing unexplained neurological deficits. *Factitious disorder* - Individuals **consciously feign or induce symptoms** to assume the sick role, without obtaining external rewards. - There is no indication the patient is intentionally producing her symptoms or faking her medical concerns; her distress appears genuine, and she is not seeking a "sick role" but rather relief from her worries. *Malingering* - Characterized by the **intentional production of false or grossly exaggerated physical or psychological symptoms** with an obvious external motivation (e.g., avoiding work, obtaining money, evading criminal prosecution). - The patient's presentation does not suggest any clear external incentives for her exaggerated concerns; her anxiety about her health appears to be the primary driver. - Note: Malingering is not classified as a mental disorder in DSM-5, but rather as a condition that may be a focus of clinical attention.
Explanation: ***Paroxetine*** - This patient presents with symptoms highly suggestive of **Generalized Anxiety Disorder (GAD)**, characterized by **persistent, excessive anxiety** and worry about various events or activities, occurring for at least six months, along with difficulty controlling the worry and associated symptoms like **sleep disturbance**, **irritability**, and **muscle tension**. - **SSRIs** like paroxetine are considered **first-line pharmacotherapy** for GAD due to their efficacy and generally favorable side-effect profile when used long-term. *Propranolol* - Propranolol is a **beta-blocker** primarily used for the **symptomatic relief** of somatic anxiety symptoms like **tremors**, **tachycardia**, and **palpitations**, often in performance anxiety. - It does **not address the core psychological symptoms** or chronic worry associated with GAD and is not a first-line treatment for the disorder itself. *Buspirone* - Buspirone is an **anxiolytic** that can be effective for GAD, particularly in patients who cannot tolerate or prefer to avoid SSRIs. - While it is a good option, it's often considered a **second-line agent** or an alternative when SSRIs are not fully effective or tolerated, rather than the initial first-line choice. *Lurasidone* - Lurasidone is an **atypical antipsychotic** primarily approved for the treatment of **schizophrenia** and **bipolar depression**. - It is **not indicated for the treatment of anxiety disorders** like GAD and would not be an appropriate first-line choice. *Alprazolam* - Alprazolam is a **benzodiazepine** that provides **rapid relief** of anxiety symptoms. - However, due to the risk of **dependence**, **tolerance**, and **withdrawal symptoms**, benzodiazepines are generally recommended for **short-term use** or for immediate symptom relief while awaiting the effects of first-line antidepressants, not as a long-term first-line monotherapy for GAD.
Explanation: ***Body dysmorphic disorder*** - The patient's preoccupation with perceived flaws in his physique (lack of musculature, scrawny appearance), excessive gym activity, dietary habits, mirror checking, camouflage (long-sleeved shirt, hat), and social avoidance (missing classes) despite normal physique strongly suggest **body dysmorphic disorder**. - **Muscle dysmorphia**, a specific form of BDD, is characterized by a preoccupation with the idea that one's body is too small or not muscular enough, often leading to excessive exercise and dietary changes, as seen in this patient. *Obsessive compulsive disorder* - While there are compulsive behaviors (mirror checking, excessive exercise), the primary driver is the preoccupation with perceived physical flaws, which is central to **body dysmorphic disorder**, not a generalized obsession or compulsion. - OCD involves recurrent, persistent thoughts (obsessions) that cause anxiety and repetitive behaviors (compulsions) performed to reduce anxiety, but the content of the obsession in BDD is specific to body image. *Avoidant personality disorder* - This disorder is characterized by a pervasive pattern of social inhibition, feelings of inadequacy, and hypersensitivity to negative evaluation, which might explain social withdrawal. - However, the core of this patient's distress is his intense preoccupation with perceived physical flaws, which drives his social avoidance, differentiating it from the general anxiety about social competence seen in **avoidant personality disorder**. *Binge eating disorder* - This disorder involves recurrent episodes of eating unusually large amounts of food in a short period, often accompanied by feelings of lack of control, distress, and guilt. - While the patient consumes a large amount of food (gallon of milk, protein shakes, 3 large meals), it's presented as part of an effort to gain muscle and address his perceived "scrawny appearance," not as uncontrolled overeating in response to distress, which is characteristic of **binge eating disorder**. *Generalized anxiety disorder* - This disorder is characterized by excessive and uncontrollable worry about a variety of events or activities for at least 6 months. - While the patient exhibits anxiety, it is specifically focused on his body image and appearance, distinguishing it from the broad, pervasive worries seen in **generalized anxiety disorder**.
Explanation: ***The patient must have symptoms of elevated autonomic activity.*** - The patient's presentation with **diaphoresis**, **shortness of breath**, and **chest pain** during these episodes are classic symptoms of **autonomic arousal**, which are central to a panic attack diagnosis. - Medical causes for these physical symptoms, such as acute coronary syndrome, have been ruled out, further supporting a psychiatric etiology involving **hyperactivity of the autonomic nervous system**. *The patient must have a fear of not being able to escape.* - While **agoraphobia** (fear of not being able to escape, often in public places) can co-occur with panic disorder, it is **not a mandatory diagnostic criterion** for panic disorder itself. - The patient’s primary anxiety described is about recurrence of the attacks and their physical sensations, not specifically about being unable to escape a particular situation. *The patients must have symptoms for at least 3 months.* - According to DSM-5 criteria, panic disorder requires at least **one month** of persistent concern or worry about additional panic attacks or their consequences, or a significant maladaptive change in behavior related to the attacks. - The 3-month timeframe mentioned in the clinical vignette describes the duration of her symptoms, but it's not a direct diagnostic threshold for the duration of symptoms. *Attacks occur at regular intervals.* - Panic attacks in panic disorder are characterized by their **unpredictable** and **spontaneous** nature, often occurring "out of the blue," rather than at regular intervals. - The lack of known triggers supports the spontaneous nature of these attacks, a hallmark of panic disorder. *There is a fixed number of attacks needed for diagnosis.* - There is **no fixed number of attacks** required for the diagnosis of panic disorder; instead, the diagnosis hinges on the presence of **recurrent, unexpected panic attacks** followed by at least one month of persistent concern about additional attacks or their consequences. - The severity and impact of the attacks, along with the subsequent worry, are more important than a specific count.
Explanation: ***Administration of fluoxetine*** - The patient's symptoms, including **parotid gland enlargement**, **eroded dental enamel**, **calluses on the knuckles (Russell's sign)**, and a history of recurrent constipation/diarrhea with normal BMI despite purging behaviors, are highly suggestive of **bulimia nervosa**. - **Fluoxetine** is the only antidepressant specifically approved by the FDA for the treatment of bulimia nervosa, demonstrating efficacy in reducing binge-eating and purging behaviors. *Administration of topiramate* - **Topiramate** is an anticonvulsant that can be used off-label for weight loss and may reduce binge-eating frequency in some individuals. - However, it is **not FDA-approved** for bulimia nervosa and its use is usually reserved for cases refractory to first-line treatments like fluoxetine, or in patients with comorbid conditions like migraines or seizures. *Administration of mirtazapine* - **Mirtazapine** is an antidepressant known for its **sedative and appetite-stimulating effects**, often leading to weight gain. - This characteristic makes it **less suitable** as a primary treatment for bulimia nervosa, where weight gain is often a significant concern for patients. *Administration of olanzapine* - **Olanzapine** is an atypical antipsychotic often associated with **significant weight gain and metabolic side effects**. - While it can be used in some eating disorders, particularly **anorexia nervosa** to aid weight restoration, it is **not indicated** as a first-line treatment for bulimia nervosa and would be counterproductive given the patient's concerns. *Administration of venlafaxine* - **Venlafaxine** is a **serotonin-norepinephrine reuptake inhibitor (SNRI)** used for depression and anxiety. - While it may have some antidepressant effects, it is **not a first-line treatment** specifically approved or recommended for bulimia nervosa in the way fluoxetine is.
Explanation: ***Prevention of withdrawal symptoms and reduced cravings*** - **Methadone maintenance therapy** is a long-acting μ-opioid receptor agonist that prevents withdrawal symptoms and reduces cravings—this is the **primary therapeutic benefit** and mechanism of action. - By providing a stable, long-acting opioid, methadone eliminates the cycle of withdrawal and drug-seeking behavior that characterizes heroin addiction. - This patient's previous quit attempt failed specifically due to **"horrible withdrawal symptoms"** and **strong cravings**, making this the most directly relevant benefit for his situation. - All other benefits of methadone maintenance (improved functioning, better relationships, reduced risk behaviors) are **secondary consequences** that stem from this primary pharmacological effect. - Evidence-based guidelines consistently identify withdrawal prevention and craving reduction as the core therapeutic goals of opioid agonist therapy. *Improved interpersonal relationships* - While this is an important **downstream benefit** of successful methadone maintenance, it is an indirect consequence rather than the primary therapeutic effect. - Improved relationships result FROM the stabilization achieved through withdrawal prevention and craving reduction, not as a direct pharmacological action. - Though clinically meaningful, this represents a **psychosocial outcome** rather than the most important direct benefit of the medication itself. *Decreases methadone dependence* - This is **incorrect**—methadone itself is an opioid agonist and patients on maintenance therapy develop **physical dependence** on methadone. - The goal is to substitute unstable illicit opioid use (heroin) with stable, medically supervised opioid therapy (methadone), not to eliminate opioid dependence immediately. - Methadone maintenance is harm reduction, not abstinence-based treatment initially. *Euphoria without the side effects* - Methadone is **not intended to produce euphoria**—it is administered at stable doses to maintain normal functioning without intoxication. - Its slow onset and long duration of action when taken orally minimize the "rush" or euphoric effects associated with rapid-acting opioids like heroin. - The goal is stabilization and normal functioning, not achieving a "high." *Reduced risk of hepatitis B and C transmission* - This is a valuable **harm reduction benefit**, particularly for those who inject drugs and share needles. - However, this patient specifically **denies sharing needles**, making this less relevant to his individual case. - More importantly, this is a secondary benefit that occurs as a result of reduced injection drug use, which itself results from the primary effect of withdrawal prevention and craving reduction.
Explanation: ***Illness anxiety disorder*** - This patient exhibits **preoccupation with having or acquiring a serious illness**, despite minimal somatic symptoms and negative diagnostic findings. Her fear of colon cancer, despite an unremarkable physical exam and negative fecal occult blood test, is a key indicator. - Her history of seeking care from multiple doctors, admitting anxiety about visits, and stating "There's gotta be something wrong with me, I can feel it," aligns with the **excessive health-related behaviors** (or maladaptive avoidance) and **high anxiety about health** central to illness anxiety disorder. *Somatic symptom disorder* - This disorder is characterized by **one or more somatic symptoms that are distressing or result in significant disruption of daily life**, accompanied by excessive thoughts, feelings, or behaviors related to these symptoms. - In this case, the patient's symptoms (bloating, fatigue) are minimal, and her primary concern is the *fear of having* a serious illness, rather than the distress caused by the physical symptoms themselves. *Generalized anxiety disorder* - This involves **excessive anxiety and worry about a number of events or activities** that is difficult to control and present for at least 6 months. - While the patient experiences anxiety, it is specifically focused on her health, not generalized concerns about various aspects of her life. *Malingering* - This involves the **intentional production of false or grossly exaggerated physical or psychological symptoms**, motivated by external incentives such as avoiding work or obtaining financial compensation. - The patient genuinely believes she has a serious illness and is distressed by this belief, rather than faking symptoms for an external gain. *Body dysmorphic disorder* - This disorder is characterized by **preoccupation with one or more perceived defects or flaws in physical appearance** that are not observable or appear slight to others. - The patient's concerns are about an internal illness (colon cancer), not specific physical appearance flaws.
Explanation: ***Appetite suppression is a common side effect of this medication.*** - The patient's symptoms (trouble focusing, scattered thoughts since childhood, difficulty focusing at school and home) are highly suggestive of **Attention-Deficit/Hyperactivity Disorder (ADHD)**. - The first-line medications for ADHD are **stimulants** (e.g., methylphenidate, amphetamines), which commonly cause **appetite suppression** and **weight loss**. *"Chronic use of this medication can lead to tardive dyskinesia."* - **Tardive dyskinesia** is a severe side effect primarily associated with **long-term use of dopamine receptor blocking antipsychotic medications**, not stimulants. - Stimulants do not typically cause tardive dyskinesia because their primary mechanism of action is increasing neurotransmitter levels, not blocking dopamine receptors. *"Hypotension is a common side effect of this medication."* - **Stimulants** typically cause an **increase in blood pressure and heart rate** (hypertension, tachycardia) due to their sympathomimetic effects, not hypotension. - **Hypotension** might be observed with certain **antihypertensive medications** or alpha-2 agonists like guanfacine or clonidine, which are sometimes used for ADHD but are not first-line stimulants. *"Bupropion is more effective than this medication for treating this disorder in adults."* - This statement is **incorrect**. **Stimulants** are the **first-line treatment** for ADHD due to their superior efficacy in improving attention and reducing hyperactivity/impulsivity. - **Bupropion** is an antidepressant that is sometimes used off-label for ADHD, but it is generally considered **less effective than stimulant medications** for treating core ADHD symptoms in adults. *"Sedation is a common side effect of this medication."* - **Stimulants** are known for their **activating effects** and typically cause **insomnia** and **nervousness**, rather than sedation. - **Sedation** is a common side effect of medications like **antihistamines, hypnotics, or some antidepressants** (e.g., trazodone), not stimulants.
Explanation: ***Depersonalization/derealization disorder*** - The patient's symptom of feeling "outside of her body" and "watching myself" is a classic description of **depersonalization**, a core feature of depersonalization/derealization disorder. - Her episodes occurring both while awake and asleep, chronic fatigue, and normal neurological exam, in the absence of other specific neurological or psychiatric symptoms, align well with this diagnosis. - **DSM-5 diagnostic criteria** include persistent or recurrent experiences of depersonalization (feeling detached from one's mental processes or body) and/or derealization (feeling detached from surroundings), with intact reality testing. *Dissociative identity disorder* - This disorder involves the presence of **two or more distinct personality states** or identities, which is not described. - Patients typically experience significant memory gaps for everyday events, personal information, and traumatic events, which are not mentioned. *Brief psychotic disorder* - This diagnosis involves the sudden onset of **psychotic symptoms** such as delusions, hallucinations, disorganized speech, or grossly disorganized/catatonic behavior, none of which are present. - The duration is specific, lasting more than 1 day but less than 1 month, and the patient's symptoms are dissociative, not psychotic. *Delusional disorder* - The primary feature of delusional disorder is the presence of **non-bizarre delusions** for at least 1 month, without other signs of psychosis. - The patient's "nightmares" and feeling "outside of her body" are experiences of depersonalization, not fixed false beliefs. *Dissociative amnesia with dissociative fugue* - In **DSM-5**, dissociative fugue is a specifier for dissociative amnesia, involving sudden, unexpected travel away from home with **inability to recall one's past**, coupled with confusion about personal identity. - The patient describes specific dissociative experiences (depersonalization) but does not mention any travel or loss of memory for personal identity.
Explanation: ***Cognitive-behavior therapy or behavior modification*** - The patient's presentation is consistent with **trichotillomania**, a condition characterized by recurrent, irresistible urges to pull out hair. **Cognitive-behavior therapy (CBT)**, specifically habit reversal training (HRT), is the first-line treatment. - **CBT** helps patients identify triggers, develop alternative coping mechanisms, and reduce hair-pulling behavior. *Clomipramine* - **Clomipramine**, a tricyclic antidepressant, has shown some efficacy in severe cases of trichotillomania, but it is typically considered a **second-line treatment** after behavioral therapies. - It has a less favorable side effect profile compared to SSRIs and behavioral therapies. *Venlafaxine* - **Venlafaxine** is a serotonin-norepinephrine reuptake inhibitor (SNRI) and is not considered a first-line treatment for trichotillomania. - While it may be used for co-occurring anxiety or depression, its direct efficacy for hair pulling is **limited** and not established as a primary treatment. *Electroconvulsive therapy* - **Electroconvulsive therapy (ECT)** is a highly invasive procedure generally reserved for severe, resistant mood disorders, like major depression with psychotic features or severe bipolar disorder. - It is **not indicated** for the treatment of trichotillomania. *Phenelzine* - **Phenelzine** is a monoamine oxidase inhibitor (MAOI) antidepressant. - MAOIs are generally reserved for **refractory depression** due to their significant dietary restrictions and potential for drug interactions, and they are not a primary treatment for trichotillomania.
Explanation: ***Obsessive compulsive disorder (OCD)*** - The patient's **repetitive behaviors** (combing dolls' hair for hours, counting steps) and her distress when confronted ("brought to tears") are classic symptoms of **obsessions** and **compulsions**. - The presence of **motor tics** also supports OCD, as tics are frequently comorbid with OCD, especially in children and adolescents. *Autism spectrum disorder (ASD)* - While ASD involves **repetitive behaviors** and restricted interests, these are typically accompanied by significant deficits in **social communication** and interaction, which are not described here. - The patient's distress when behaviors are interrupted points more towards anxiety inherent in OCD rather than the rigid adherence common in ASD. *Generalized anxiety disorder (GAD)* - GAD is characterized by **excessive worry** about various events or activities, often difficult to control, and associated with physical symptoms like restlessness or fatigue. - While the patient experiences distress, the primary issue is specific, intrusive thoughts and repetitive actions, not generalized worry. *Major depressive disorder (MDD)* - MDD involves a persistent period of **depressed mood** or **loss of interest/pleasure** along with other symptoms like changes in appetite, sleep, or energy. - The patient's primary symptoms are repetitive behaviors and distress, not the core features of depression, although secondary distress could occur. *Tourette's syndrome* - Tourette's syndrome is characterized by **multiple motor tics** and at least one **vocal tic** for over a year. - While the patient has occasional motor tics, the predominant and distressing symptoms are the obsessive thoughts and compulsive behaviors, which are the hallmarks of OCD, a disorder often comorbid with tic disorders.
Explanation: ***Trazodone*** - This patient presents with symptoms highly suggestive of **post-traumatic stress disorder (PTSD)**, including insomnia, hypervigilance, and intrusive memories, potentially exacerbated by attending a friend's funeral. **Trazodone** is an antidepressant with prominent sedating effects that can be particularly useful for managing **insomnia and nightmares associated with PTSD**, especially in elderly patients, without the highly addictive properties of benzodiazepines. - Given the patient's age and multiple comorbidities, a medication with a favorable side effect profile for sleep is preferred. Trazodone is generally well-tolerated at lower doses for sleep and avoids the cognitive and dependence risks of other sleep aids like benzodiazepines. *Escitalopram* - While **SSRIs like escitalopram** are first-line treatments for the core symptoms of PTSD, they often take several weeks to achieve their full therapeutic effect and do not provide immediate relief for the severe insomnia and nightmares that are most distressing to this patient. - Escitalopram can sometimes initially worsen sleep disturbances, making it less ideal as a rapid initial therapy for severe insomnia in an elderly patient. *Clonazepam* - **Benzodiazepines like clonazepam** can provide quick relief for anxiety and insomnia, but they are generally discouraged in elderly patients due to the high risk of **sedation, cognitive impairment, falls, and potential for dependence and withdrawal symptoms**. - In a patient with PTSD, benzodiazepines may also **interfere with fear extinction** and proper processing of traumatic memories, potentially hindering long-term recovery. *Buspirone* - **Buspirone** is an anxiolytic that can be used to treat generalized anxiety disorder, but it has no significant hypnotic or sedative effects and would not adequately address the patient's primary complaint of severe insomnia and nightmares. - Its onset of action is also slow, typically taking 2-4 weeks to show noticeable anxiolytic effects, making it unsuitable for acute management of severe sleep disturbance. *Bupropion* - **Bupropion** is an antidepressant that works via dopamine and norepinephrine reuptake inhibition. It is generally considered an **activating antidepressant** and can frequently cause or worsen insomnia, rather than alleviating it. - Bupropion is not effective for PTSD and is contraindicated in patients with a history of seizures or eating disorders.
Explanation: ***Sleep terror disorder*** - This patient's presentation with sudden nocturnal screaming, agitation, autonomic arousal (sweating, fast breathing), and subsequent **amnesia** for the event is classic for **sleep terror disorder**. - The inability of parents to awaken or comfort the child, followed by the child returning to sleep and having **no recall**, are key diagnostic features. *Restless legs syndrome* - Characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations, typically occurring or worsening during periods of **rest** or **inactivity**, and partially or totally relieved by movement. - This condition does not involve screaming, intense fear, or amnesia for a sleep event. *Nightmare disorder* - Nightmares are typically **vivid, frightening dreams** from which the individual awakens fully alert and often recalls the dream in detail. - Unlike sleep terrors, nightmares occur during **REM sleep** (usually later in the night), and the child is usually consolable after waking. *Sleepwalking disorder* - Involves complex motor behaviors, such as walking, while still asleep, without full consciousness. - While it can occur during NREM sleep and involves partial amnesia, it typically **does not feature screaming, intense fear, or significant autonomic arousal** as the predominant symptom. *Insomnia disorder* - Defined by persistent difficulty with **sleep initiation, duration, consolidation, or quality**, despite adequate opportunity for sleep, leading to daytime impairment. - It does not involve acute episodes of screaming or terror during sleep as described.
Explanation: ***Selective mutism*** - This condition is characterized by a **consistent failure to speak** in specific social situations where speaking is expected (e.g., school, church) despite speaking in other situations (e.g., home, with friends). - The child's excellent speech and language skills at home, coupled with significant anxiety-driven silence in public settings, are classic signs of **selective mutism**, not a general developmental delay. *Normal development* - While shyness is common in children, the complete lack of speech in specific, ongoing social settings like school and church, despite fluent speech at home, goes beyond typical shyness and indicates a **clinical concern**. - A child who refuses to speak to teachers after 5 months, even with fluent home speech, suggests a **pattern inconsistent with normal social-emotional development**. *Child abuse at school* - While abuse can cause behavioral changes, the child’s continued silence and shyness in other settings like church, where abuse is unlikely, makes **abuse at school less probable** as the primary explanation. - The child's ability to speak fluently at home also makes a specific school-related trauma less likely to be the **sole cause** of his mutism in other public settings. *Expressive speech delay* - The child's ability to speak in **4-word sentences**, tell stories, be 100% understood by parents, name colors, and recognize letters indicates **age-appropriate or advanced expressive language skills** in familiar settings. - An expressive speech delay would imply difficulty with *producing* speech or vocabulary regardless of the setting, which is not the case here. *Autism spectrum disorder* - While individuals with ASD may avoid eye contact and have social communication challenges, the child's fluent and complex speech at home and with friends makes **ASD less likely**, as pervasive communication deficits across all environments are characteristic. - The **situational specificity** of the mutism, rather than a global communication impairment, points away from ASD.
Explanation: ***Panic disorder and agoraphobia*** - The patient experiences **recurrent unexpected panic attacks** ("feels short of breath, sweaty, feels like her heart wants to jump out her chest") and persistent worry about additional attacks or their consequences, consistent with **panic disorder**. - Her active avoidance of specific places ("subway, crowded pharmacy, slow and poorly lit elevator") and fear that she "may not be able to get the help she needs or escape if needed" in these situations is characteristic of **agoraphobia**. *Panic disorder* - While the patient clearly has panic attacks and associated worry, this option is incomplete as it does not account for the prominent **agoraphobic avoidance behaviors** described. - The patient's **fear of being trapped or unable to escape** in specific situations points beyond just panic disorder. *Agoraphobia* - This diagnosis focuses solely on the **fear of situations from which escape might be difficult or help unavailable**, leading to avoidance. - However, it does not fully encompass the initial presentation of **sudden, unexpected panic attacks** and the "going crazy" feeling that precedes the avoidance. *Generalized anxiety disorder* - This disorder involves **persistent, excessive worry** about various aspects of life for at least six months, often accompanied by symptoms like muscle tension and difficulty concentrating. - The patient's symptoms are specifically tied to discrete panic attacks and avoidance behaviors, rather than diffuse, generalized worry. *Social anxiety disorder* - This condition is characterized by **intense fear or anxiety about social situations** where one might be scrutinized or judged negatively. - The patient's fear is related to being in places where escape might be difficult or help unavailable during a panic attack, not primarily about social evaluation.
Explanation: ***Functional neurological symptom disorder (Conversion disorder)*** - This patient presents with **neurological symptoms (pseudoseizures)** inconsistent with known neurological conditions, following a significant **psychological stressor (sexual assault).** - Key features like **resistance to eye opening**, **arrhythmic thrashing**, **eyes closed during episode**, and general atypical presentation for a true seizure strongly suggest functional neurological symptom disorder (conversion disorder), as these are classic features of *psychogenic non-epileptic seizures (PNES)*. - The temporal relationship to trauma and absence of prior seizure history further support this diagnosis. *Body dysmorphic disorder* - This disorder involves a **preoccupation with perceived flaws in physical appearance**, which are often minor or not observable to others. - The patient's symptoms of pseudoseizures and thrashing are **neurological manifestations** and do not align with concerns about physical appearance. *Somatic symptom disorder* - This diagnosis involves **one or more somatic symptoms that are distressing or result in significant disruption** of daily life, with **excessive thoughts, feelings, or behaviors** related to the somatic symptoms. - While somatic symptom disorder can include neurological complaints, the acute presentation of pseudoseizures with specific neurological signs (eye closure resistance, arrhythmic movements) directly linked to recent severe trauma makes functional neurological symptom disorder the more precise diagnosis. *Illness anxiety disorder* - Characterized by a **preoccupation with having or acquiring a serious illness** based on misinterpretation of bodily symptoms, with minimal or no somatic symptoms present. - The patient is experiencing active neurological symptoms (pseudoseizures), not health anxiety or unfounded fear of having an illness. *Somatic symptom disorder with predominant pain* - In this specifier, the primary symptom is **pain**, which is distressing and associated with excessive thoughts, feelings, or behaviors related to the pain. - The patient's primary presentation is **pseudoseizures with motor symptoms**, not pain, making this diagnosis inconsistent with her clinical picture.
Explanation: **Escitalopram** - The patient presents with **generalized anxiety disorder (GAD)** symptoms, including excessive worry, restlessness, sleep disturbances, difficulty concentrating, and somatic symptoms, for over 6 months; **selective serotonin reuptake inhibitors (SSRIs)** like escitalopram are first-line pharmacotherapy. - SSRIs are effective in reducing both psychological and physical symptoms of GAD and have a favorable side effect profile compared to other antidepressant classes. *Clonazepam* - Clonazepam, a **benzodiazepine**, provides rapid symptom relief for acute anxiety but is associated with risks of **dependence, tolerance, and withdrawal** with long-term use. - It is generally reserved for short-term use during the initial phase of treatment or for acute exacerbations, not as monotherapy for chronic GAD due to its side effects and risk profile. *Amitriptyline* - Amitriptyline is a **tricyclic antidepressant (TCA)** that can be used for anxiety but has a less favorable side effect profile (e.g., **anticholinergic effects, cardiac toxicity**) compared to SSRIs. - Given the availability of safer and equally effective alternatives like SSRIs, TCAs are not typically considered first-line for GAD. *Propranolol* - Propranolol is a **beta-blocker** that primarily targets the physical symptoms of anxiety, such as **tremor, palpitations, and sweating**. - It is effective for **performance anxiety** or specific phobias but does not address the cognitive and psychological symptoms of generalized anxiety disorder. *Buspirone* - Buspirone is an **anxiolytic** that acts on 5-HT1A serotonin receptors and is effective for GAD, but its **onset of action is slow** (several weeks), making it less suitable for initial monotherapy when rapid symptom control is desired. - It lacks the antidepressant properties of SSRIs, which may be beneficial given the patient's general distress and possible co-existing depressive symptoms.
Explanation: ***Bulimia nervosa*** - This patient exhibits characteristic features of bulimia nervosa, including recurrent episodes of **binge eating** (at least twice weekly) followed by inappropriate **compensatory behaviors**. - The **bilateral parotid gland enlargement** and **lingual enamel erosion** are **pathognomonic physical signs of chronic self-induced vomiting** (purging behavior), combined with excessive exercise as additional compensation. - Her normal BMI of 21 kg/m² is highly consistent with bulimia nervosa, as individuals with this condition typically maintain a **normal weight or are overweight**, unlike those with anorexia nervosa. - The sense of **loss of control** and **shame** about eating episodes are core features of this disorder. *Borderline personality disorder* - While **self-harm** (cutting) can be associated with borderline personality disorder, the primary concern in this patient is the prominent eating disorder symptoms with pathognomonic physical findings. - Borderline personality disorder is characterized by a pervasive pattern of **instability in interpersonal relationships**, self-image, affects, and marked impulsivity; these are not the main presenting complaints here. - Self-harm behavior can occur in multiple psychiatric conditions and does not alone establish this diagnosis. *Body dysmorphic disorder* - This disorder involves a **preoccupation with perceived flaws in physical appearance** that are minimal or unobservable to others, leading to significant distress or impairment. - While the patient is concerned about gaining weight, her primary symptoms revolve around **binge-purge cycles** with physical evidence of purging behavior, rather than a sole preoccupation with a specific body defect. *Anorexia nervosa* - Anorexia nervosa is characterized by **restriction of energy intake** leading to a significantly low body weight (BMI usually <17.5 kg/m²) and intense fear of gaining weight despite being underweight. - This patient has a **normal BMI (21 kg/m²)** and engages in binge-eating followed by compensatory behaviors (purging and exercise), which represents bulimia nervosa rather than anorexia nervosa. - Additionally, she has **regular menses** (last period 3 weeks ago), whereas amenorrhea is common in anorexia nervosa due to low body weight. *Obsessive-compulsive disorder* - OCD involves recurrent, persistent, **intrusive thoughts (obsessions)** and/or repetitive behaviors or mental acts that an individual feels driven to perform **(compulsions)** to reduce anxiety. - While some of the patient's behaviors might seem ritualistic, the core symptoms are clearly related to **eating disorder pathology with binge-purge cycles**, not typical OCD themes like contamination, symmetry, or checking behaviors. - The physical signs of chronic purging behavior definitively point to an eating disorder diagnosis.
Explanation: ***Buspirone*** - This patient's symptoms of **generalized anxiety, sleep disturbances**, and **difficulty concentrating** suggest **generalized anxiety disorder (GAD)**. Buspirone is an **anxiolytic** that is often used for GAD, particularly when there is a risk of substance abuse or a need to avoid sedation. - It works by agonizing **serotonin type 1A receptors (5-HT1A)** and lacks the sedative and dependence potential of benzodiazepines, making it a good choice for long-term treatment. *Valerian* - **Valerian root** is an herbal supplement sometimes used for **insomnia** and anxiety. - However, there is **limited scientific evidence** to support its efficacy for generalized anxiety disorder, and it is not a first-line pharmacological treatment. *Doxepin* - **Doxepin** is a **tricyclic antidepressant (TCA)** with significant **sedating and anticholinergic side effects**. - While it can be used for anxiety, it is generally **not preferred** due to its side effect profile, especially in a young patient where a less sedating option like buspirone is available. *Propranolol* - **Propranolol** is a **beta-blocker** primarily used to treat the **physical symptoms of anxiety**, such as palpitations and tremors, often in performance anxiety. - It does **not address the cognitive and psychological symptoms** of generalized anxiety disorder, such as worry and restlessness. *Lorazepam* - **Lorazepam** is a **benzodiazepine** that provides rapid relief of anxiety symptoms. - However, due to the **risk of dependence, sedation, and withdrawal symptoms**, and the patient's history of excessive alcohol use, it is generally **not preferred for long-term management of GAD**, especially as a first-line agent.
Explanation: ***A 35-year-old male that gets tachycardic, tachypnic, and diaphoretic every time he rides a plane*** - Alprazolam is a **benzodiazepine** commonly used for the acute, short-term management of **panic attacks** and specific phobias due to its rapid onset of action. The symptoms described (tachycardia, tachypnea, diaphoresis) are classic signs of a panic attack triggered by a specific phobia (fear of flying). - For **acute anxiety** or panic related to specific phobic situations, alprazolam can be prescribed for use **as needed** to alleviate intense symptoms. *A 19-year-old male that saw his sibling murdered, and has had flashbacks and hypervigilance for more than one month* - This presentation suggests **post-traumatic stress disorder (PTSD)** due to the nature of the trauma and the duration of symptoms. Benzodiazepines like alprazolam are generally **contraindicated for long-term use in PTSD** because they can interfere with trauma processing and have a high risk of dependence and abuse. - First-line treatments for PTSD typically involve **selective serotonin reuptake inhibitors (SSRIs)** and **trauma-focused psychotherapy**. *A 28-year-old female that gets irritated or worried about everyday things out of proportion to the actual source of worry* - This describes symptoms consistent with **generalized anxiety disorder (GAD)**. While alprazolam can provide short-term relief, it is **not recommended for long-term management of GAD** due to the risk of tolerance and dependence. - **SSRIs/SNRIs** and **cognitive-behavioral therapy (CBT)** are the preferred long-term treatments for GAD. *A 42-year-old female with extreme mood changes ranging from mania to severe depression* - This presentation is highly indicative of **bipolar disorder**. Alprazolam (a benzodiazepine) **does not treat bipolar disorder** and could potentially worsen mania or contribute to rapid cycling in some individuals. - Treatment for bipolar disorder involves **mood stabilizers** (e.g., lithium, valproate) and sometimes atypical antipsychotics. *A 65-year-old male with narrow angle glaucoma that complains of excessive worry, rumination, and uneasiness about future uncertainties* - This patient's symptoms could suggest an anxiety disorder, but the presence of **narrow-angle glaucoma** is a **contraindication for benzodiazepines** like alprazolam, as they can cause mydriasis (pupil dilation) leading to an acute attack of angle-closure glaucoma. - For anxiety in elderly patients, especially with comorbidities, non-pharmacological interventions or other anxiolytics with a safer profile would be considered.
Explanation: ***Lorazepam*** - The patient is exhibiting symptoms of **alcohol withdrawal**, including anxiety, tremors, restlessness, diaphoresis, hypertension, and tachycardia, which require treatment with a **benzodiazepine**. - **Lorazepam** is a short-to-intermediate acting benzodiazepine that is preferred in patients with **liver disease** (indicated by elevated AST/ALT and tender hepatomegaly) because it is metabolized by glucuronidation and does not rely on oxidative hepatic metabolism. *Chlordiazepoxide* - **Chlordiazepoxide** is a long-acting benzodiazepine primarily metabolized by the **liver's oxidative pathways**, which can accumulate and lead to toxicity in patients with liver dysfunction. - While effective for alcohol withdrawal, its long half-life and hepatic metabolism make it less ideal for patients with signs of **liver injury** such as this patient with elevated AST/ALT and hepatomegaly. *Risperidone* - **Risperidone** is an atypical antipsychotic primarily used to treat **psychosis** or severe agitation, not the core symptoms of alcohol withdrawal. - It does not address the underlying **neurotransmitter imbalance** (GABAergic hypofunction) characteristic of alcohol withdrawal. *Thiamine* - **Thiamine** (vitamin B1) is essential for preventing **Wernicke-Korsakoff syndrome** in patients with chronic alcohol use, and should be administered in this patient. - However, thiamine does not alleviate the acute symptoms of alcohol withdrawal like anxiety, tremors, or autonomic hyperactivity. *Haloperidol* - **Haloperidol** is a potent antipsychotic that can be used for severe agitation or psychotic symptoms, but it **lowers the seizure threshold**, which is particularly dangerous in alcohol withdrawal where seizure risk is already elevated. - It does not provide the anxiolytic or sedative effects needed to reverse the **GABAergic hypofunction** seen in alcohol withdrawal syndrome.
Explanation: ***Anorexia nervosa*** - The patient presents with **significant weight loss**, **fatigue**, social withdrawal, and physical signs such as **dry skin**, **brittle nails**, and **bradycardia**, all consistent with anorexia nervosa. - While not explicitly stated, the **calluses on the knuckles (Russell's sign)** often indicate self-induced vomiting, which is a common compensatory behavior in eating disorders, even those primarily restrictive like anorexia nervosa. *Anemia* - While the patient appears pale, her **hemoglobin level of 12.3 g/dL** is within the normal range for a female, ruling out anemia as the primary diagnosis. - Pallor in this context is more likely due to **poor nutrition** and overall debilitation associated with an eating disorder. *Major depressive disorder* - The patient exhibits symptoms like **fatigue**, weight loss, and social withdrawal, which can be seen in major depressive disorder, and her mother has a history of it. - However, the additional physical findings (dry skin, brittle nails, bradycardia, **calluses on knuckles**) and the specific pattern of **weight loss** points more strongly towards an eating disorder. *Milk-alkali syndrome* - This syndrome is characterized by **hypercalcemia** (Ca+2 > 10.5 mg/dL), metabolic alkalosis (increased HCO3-), and often **renal insufficiency**, usually due to excessive intake of calcium and absorbable alkali. - The patient's **hypocalcemia (Ca+2 7.8 mg/dL)** and slightly elevated HCO3- (30 mEq/L) are inconsistent with milk-alkali syndrome. *Bulimia nervosa* - Bulimia nervosa is characterized by **recurrent episodes of binge eating** followed by compensatory behaviors such as purging (self-induced vomiting, laxative abuse). The presence of **Russell's sign** (calluses on knuckles) suggests purging. - However, patients with bulimia nervosa typically maintain a **normal body weight or are overweight**, unlike this patient who has significant weight loss and a BMI at the 20th percentile, which makes anorexia nervosa with purging subtype more likely.
Explanation: ***Refer for psychological evaluation and assessment of school-related factors*** - This child presents with **somatic symptoms (abdominal pain) that occur exclusively at school and resolve completely at home**, which is pathognomonic for **separation anxiety disorder** or **school avoidance** with somatization. - The workup has already ruled out organic causes: **normal physical exam, normal labs (BMP, CBC), normal stool characteristics**, and no red flags for gastrointestinal pathology. - In a **5-year-old** child with this pattern, the next appropriate step is **psychological evaluation** to assess for anxiety disorders, school-related stressors, or adjustment issues. - This aligns with the question's topic of **Anxiety** in Psychiatry. *Perform a stool culture* - There are **no clinical indicators of infectious gastroenteritis**: the child has normal stool consistency, no blood, no diarrhea, and is **completely asymptomatic at home**. - If this were **Bacillus cereus** or another foodborne pathogen, symptoms would persist regardless of location and would include diarrhea or vomiting within hours of ingestion. - The temporal pattern (symptoms only at school) indicates a **psychogenic rather than infectious etiology**. *Begin treatment with ciprofloxacin* - Empiric antibiotics are inappropriate without evidence of bacterial infection. - The child has **no fever, no bloody stools, no diarrhea**, and normal labs, making bacterial gastroenteritis highly unlikely. - Starting antibiotics would expose the child to unnecessary side effects and contribute to antimicrobial resistance. *Increase oral hydration and fiber intake* - This intervention addresses **constipation**, which is not present in this case. - The child has **normal stool consistency and frequency** with no difficulty passing stool, making this intervention irrelevant. *Check the stool for fecal red blood cells and leukocytes* - While these tests can identify inflammatory processes, they are unnecessary given the **normal stool characteristics** and **absence of constitutional symptoms**. - The clear **temporal association with school attendance** and resolution at home makes an organic gastrointestinal process extremely unlikely. - Further invasive testing would delay appropriate psychiatric evaluation and potentially reinforce illness behavior.
Explanation: ***Conversion disorder*** - The patient presents with neurological symptoms (left-sided weakness, unsteady gait) that are **inconsistent with anatomical pathways or known neurological disease** (e.g., inability to plantarflex while supine but able to stand on toes). - The imaging studies (CT, MRI, MRA) are **normal**, further ruling out organic causes for the neurological deficits, and the recent psychosocial stressor (job loss) is a common trigger. *Somatic symptom disorder* - Characterized by one or more **somatic symptoms that are distressing or result in significant disruption of daily life**, accompanied by excessive thoughts, feelings, or behaviors related to those symptoms. - While there are somatic symptoms here, the presentation is more specifically aligned with neurological deficits, and the lack of excessive health-related thoughts makes conversion disorder a better fit. *Acute stress disorder* - Involves the development of **anxiety, dissociative, and other symptoms within one month of exposure to a traumatic event**. - While job loss is stressful, the primary presentation is neurological symptoms rather than overt anxiety or dissociative phenomena, making it less likely. *Acute hemorrhagic stroke* - Would typically present with **sudden onset focal neurological deficits**, but these would be consistent with known neuroanatomy. - A **CT scan of the head would show abnormalities** (e.g., hemorrhage), which was negative in this patient. *Malingering* - Characterized by the **intentional production of false or grossly exaggerated physical or psychological symptoms** motivated by external incentives (e.g., avoiding work, financial compensation). - There is no evidence of external gain or intentional deception in this case; conversion disorder symptoms are not consciously produced.
Explanation: ***Sertraline*** - The patient exhibits classic symptoms of **Obsessive-Compulsive Disorder (OCD)**, including recurrent, intrusive thoughts (**obsessions**) causing distress and repetitive behaviors (**compulsions**) aimed at reducing anxiety. - **Selective Serotonin Reuptake Inhibitors (SSRIs)** like sertraline are the first-line pharmacotherapy for OCD, often requiring higher doses than for depression or anxiety. *Olanzapine* - **Olanzapine** is an atypical antipsychotic and is typically used to treat conditions like schizophrenia or bipolar disorder. - It would not be the initial treatment choice for OCD, though it might be considered as an **adjunct** in cases of severe, treatment-refractory OCD. *Venlafaxine* - **Venlafaxine** is a serotonin-norepinephrine reuptake inhibitor (SNRI), which can be effective for anxiety and depression. - While it has some serotonergic activity, **SSRIs are generally preferred as first-line** for OCD due to more robust evidence. *Risperidone* - **Risperidone** is an atypical antipsychotic, similar to olanzapine, used for conditions such as schizophrenia and bipolar disorder. - It is not a first-line treatment for OCD but may be used as an **augmentation strategy** for patients who do not respond to adequate trials of SSRIs. *Phenelzine* - **Phenelzine** is a monoamine oxidase inhibitor (MAOI), an older class of antidepressants with a broad range of side effects and significant dietary restrictions. - While effective for some mood and anxiety disorders, MAOIs are generally reserved for cases of **treatment-resistant depression** or anxiety due to their challenging side effect profile and drug interactions.
Explanation: ***Excessive hand washing*** * **Tourette syndrome** frequently co-occurs with **obsessive-compulsive disorder (OCD)** in 30-50% of cases, which can manifest as repetitive behaviors such as excessive hand washing, checking rituals, or other compulsions. * The patient's symptoms of involuntary "shaking his hands" (motor tics) and "loud grunting sounds" (vocal tics) persisting for over a year are diagnostic of **Tourette syndrome**. * While the vignette doesn't explicitly mention hand washing, the question asks what is **"most likely also found"** — meaning we should screen for the most common associated conditions. **OCD is a classic comorbidity** that clinicians actively look for in Tourette syndrome patients. *Intellectual disability* * While individuals with neurodevelopmental disorders can have intellectual disability, it is **not a defining or consistently associated feature of Tourette syndrome**. * Most children with Tourette syndrome have **normal intelligence**. The information provided does not suggest cognitive impairment; the child is playing with toys appropriately. *Cough that occurs only at night* * A nocturnal cough can be a symptom of **asthma**, which the patient has a history of. However, it's a symptom related to his asthma and **not directly linked to Tourette syndrome**. * This is part of his medical history but does not represent a comorbidity of the primary neuropsychiatric condition being addressed. *Auditory hallucinations* * **Auditory hallucinations** are not associated with **Tourette syndrome** or OCD. * These are more commonly found in psychotic disorders like **schizophrenia** or severe mood disorders, which are not suggested by the patient's presentation. *Poor communication skills* * Although the child is described as "mistrustful, does not reply to your questions, and does not look you in the eyes," these behaviors may stem from **anxiety, social discomfort related to his tics, or possible comorbid ADHD** (present in 50-70% of Tourette's cases). * While some social difficulties are **already evident in the vignette**, the question asks what else is "most likely also found." **OCD is a more specific, screenable comorbidity** that clinicians actively assess for in Tourette syndrome, whereas the communication difficulties described could have multiple etiologies and are already partially manifested. * If significant communication impairment were the primary concern, we would expect more developmental history and functional impact to be described.
Explanation: ***Symptoms are ego-dystonic*** - The patient's statement that she has "this irrational idea that her hands are dirty" and "tries her best to ignore these thoughts but eventually succumbs" indicates that her obsessive thoughts and compulsive behaviors are **ego-dystonic**, meaning they are inconsistent with her self-perception and desired way of functioning. - This characteristic is a hallmark of **Obsessive-Compulsive Disorder (OCD)**, where intrusive thoughts and repetitive behaviors are recognized as irrational or excessive by the individual. *The condition is associated with early onset dementia* - **Obsessive-Compulsive Disorder (OCD)** is not associated with early-onset dementia; it primarily involves anxiety-related symptoms and behavioral patterns. - While significant psychological stress can impact cognitive function, OCD itself does not typically lead to neurodegenerative conditions like dementia. *The condition rarely affects daily functioning* - The patient's admission that her symptoms led to "difficulty maintaining a clean and happy household" demonstrates that her condition **significantly impairs her daily functioning**. - **OCD** is known to cause considerable distress and can severely interfere with social, occupational, and personal activities, often becoming very time-consuming. *The condition is readily treatable* - While OCD is treatable with therapies like **cognitive-behavioral therapy (CBT)**, specifically **exposure and response prevention (ERP)**, and medications such as **SSRIs**, it is generally considered a **chronic condition** that requires ongoing management and is not "readily treatable" in the sense of a quick and easy cure. - The effectiveness of treatment varies, and many patients experience persistent symptoms, requiring long-term commitment to therapy. *Patients generally lack insight* - The patient's statement that she acknowledges her idea that her hands are dirty is "irrational" and that she "tries her best to ignore these thoughts" indicates a **recognition of the irrationality of her obsessions**, which suggests she has a good level of insight. - Patients with OCD often have significant insight into their symptoms, which distinguishes it from psychotic disorders.
Explanation: ***Escitalopram*** - The patient exhibits symptoms consistent with **Generalized Anxiety Disorder (GAD)**, characterized by excessive, uncontrollable worry about multiple events or activities. **SSRIs like escitalopram** are first-line agents for long-term treatment of GAD. - The patient's long-standing pattern of worry, despite a secure job and financial stability, and his wife's observation that he "has always worried about something," further support a diagnosis of GAD, for which escitalopram provides effective long-term symptom management. *Risperidone* - **Risperidone** is an **antipsychotic medication** primarily used for conditions like schizophrenia, bipolar disorder, and agitation. - It is not indicated as a first-line or long-term treatment for Generalized Anxiety Disorder and carries a higher risk of side effects compared to SSRIs. *Lithium* - **Lithium** is a **mood stabilizer** primarily used in the management of bipolar disorder. - This patient's symptoms are indicative of an anxiety disorder, not a mood disorder like bipolar disorder, making lithium an inappropriate choice. *No treatment recommended* - The patient's worries are severe enough to **interfere with his daily activities**, indicating a significant functional impairment. - Therefore, treatment is warranted to alleviate symptoms and improve his quality of life. *Diazepam* - **Diazepam** is a **benzodiazepine**, effective for acute anxiety relief due to its rapid onset of action. - However, it is generally **not recommended for long-term management** due to the risk of dependence, tolerance, and withdrawal symptoms.
Explanation: ***Cognitive behavioral therapy*** - This patient presents with symptoms highly suggestive of **generalized anxiety disorder (GAD)**, characterized by persistent worry about various life situations (academics, relationships) and difficulty sleeping. **Cognitive behavioral therapy (CBT)** is considered a first-line treatment for GAD, addressing maladaptive thought patterns and behaviors. - CBT could also address the patient's specific social anxiety related to presentations, by teaching coping mechanisms and restructuring negative thoughts about social situations. *Duloxetine* - **Duloxetine** is a **serotonin-norepinephrine reuptake inhibitor (SNRI)**, which is an appropriate pharmacological treatment for GAD. However, initial management for anxiety disorders, especially in a patient expressing concern about medication side effects or preference for non-pharmacological approaches, often prioritizes psychotherapy like CBT. - While it could be considered, it is typically not the *best initial step* before exploring non-pharmacological options, given the patient's concerns are not immediately life-threatening and psychotherapeutic options have high efficacy. *Fluoxetine* - **Fluoxetine** is a **selective serotonin reuptake inhibitor (SSRI)** and is a first-line pharmacological treatment for GAD. - Similar to duloxetine, while an effective medication, it is not always the *best initial step* as many patients prefer to try psychotherapy first, and it doesn't address the underlying maladaptive thought processes in the same way CBT does. *Alprazolam during presentations* - **Alprazolam** is a **benzodiazepine** that provides rapid relief of anxiety symptoms. However, it is primarily used for **acute, short-term anxiety**, not as a long-term solution for generalized anxiety or social anxiety. - Chronic use of benzodiazepines carries risks of **tolerance, dependence, and withdrawal symptoms**, making it unsuitable as an initial management strategy for persistent anxiety. *Propranolol during presentations* - **Propranolol** is a **beta-blocker** that can help manage the **physical symptoms of performance anxiety** (e.g., tremors, palpitations) by blocking adrenergic receptors. - While helpful for specific situations like presentations for social anxiety, it does not address the underlying cognitive distortions or generalized anxiety disorder, and therefore is not the best initial comprehensive management approach.
Explanation: ***Propranolol*** - **Propranolol**, a **non-selective beta-blocker**, administered shortly after a traumatic event, may **reduce the risk** of developing **post-traumatic stress disorder (PTSD)**. - It works by blocking the **neurobiological effects of stress hormones** like norepinephrine on memory **consolidation**, potentially mitigating the formation of traumatic memories. *Buspirone* - **Buspirone** is an **anxiolytic medication** primarily used for **generalized anxiety disorder (GAD)** but is not effective in preventing or acutely treating PTSD. - It has a delayed onset of action and is not typically used in situations requiring rapid intervention for trauma. *Zolpidem* - **Zolpidem** is a **sedative-hypnotic** primarily used for **insomnia** by affecting GABA receptors. - It does not address the underlying pathology of PTSD or prevent its development. *Sertraline* - **Sertraline**, an **SSRI**, is a first-line treatment for established PTSD symptoms. - However, it is not typically used as a **preventative measure immediately following a traumatic event** to avert the development of the disorder. *Prazosin* - **Prazosin**, an **alpha-1 adrenergic antagonist**, is often used to treat **PTSD-related nightmares** and sleep disturbances. - While effective for managing specific symptoms of PTSD, it is not considered a primary preventative agent administered immediately post-trauma to inhibit disorder development.
Explanation: ***A drug that blocks dopamine 2 receptors*** - This option describes **first-generation antipsychotics**, which primarily block **dopamine D2 receptors**. These are generally used for psychotic disorders (e.g., schizophrenia) and severe agitation, not typically for generalized anxiety disorder as a first-line treatment. - Blocking D2 receptors can lead to **extrapyramidal symptoms** and is not a common therapeutic target for anxiety, which is more reliably treated by targeting serotonin, norepinephrine, and GABA systems. *A drug that stimulates 5-HT1A receptors* - This describes **buspirone**, an anxiolytic that is effective for **generalized anxiety disorder (GAD)**. - **Stimulation of 5-HT1A receptors** helps to modulate serotonin activity and reduce anxiety without significant sedative effects or risk of dependence associated with benzodiazepines. *A drug that acts as a GABA agonist* - This describes **benzodiazepines**, which enhance the inhibitory effects of **GABA** in the central nervous system. - They are effective for acute anxiety relief but carry risks of **sedation**, **tolerance**, and **dependence**, making them suitable mainly for short-term or intermittent use. *A drug that blocks 5-HT reuptake* - This describes **selective serotonin reuptake inhibitors (SSRIs)**, which are considered first-line treatment for various anxiety disorders, including GAD. - By increasing **serotonin levels** in the synaptic cleft, SSRIs help to regulate mood and reduce anxiety symptoms over time. *A drug that blocks both serotonin and norepinephrine reuptake* - This describes **serotonin-norepinephrine reuptake inhibitors (SNRIs)**, such as venlafaxine or duloxetine. - SNRIs are also first-line treatments for GAD, working by increasing both **serotonin** and **norepinephrine** in the brain, offering broad-spectrum anxiolytic and antidepressant effects.
Explanation: ***Nightmare disorder*** - The key features supporting **nightmare disorder** are vivid, frightening dreams that lead to waking up, the ability to recall the dream content, being easily consolable, and attempts to avoid bedtime. - Sleep disturbances, daytime fatigue, and negative emotional responses centered around sleep are characteristic of this disorder. *Normal development* - While occasional bad dreams are part of normal development, a frequency of one to two times per week over 2 months, leading to daytime tiredness and bedtime avoidance, suggests a **clinical disorder** exceeding typical developmental experiences. - The distress caused and impact on daily functioning (tiredness at school) differentiate it from normal, transient nightmares. *Sleep terror disorder* - **Sleep terrors** typically involve abrupt awakening with intense fear, screaming, and autonomic arousal, but the individual is usually disoriented, inconsolable, and has no recall of the event upon waking or the next day. - In this case, the child is consolable and *recalls* having a bad dream, distinguishing it from sleep terrors. *Post-traumatic stress disorder* - **PTSD** requires exposure to a traumatic event, which is not mentioned in the vignette. - While nightmares can be a symptom of PTSD, they are usually accompanied by other symptoms like flashbacks, avoidance behavior, negative alterations in cognition/mood, and hypervigilance related to the trauma. *Separation anxiety disorder* - **Separation anxiety disorder** is characterized by excessive fear or anxiety concerning separation from attachment figures. - Although the child sleeps in her parents' bed, the primary issue is frightening dreams and difficulty sleeping, not anxiety specifically related to separation from her parents.
Explanation: ***Obsessive-compulsive disorder*** - The patient exhibits persistent, intrusive thoughts about his stool ("thinking about all the ways his stool is abnormal," "still thinking about his stool"), which are characteristic *obsessions*. - His repetitive behaviors of inspecting his stool and seeking reassurance from multiple physicians, despite being told it is normal, align with *compulsions* performed in response to these obsessions. *Generalized anxiety disorder* - This involves *excessive worry* about multiple aspects of life, not typically focused on a specific, circumscribed concern like stool appearance, and usually impacts daily functioning more broadly. - While anxiety is present, the specific *obsessive thought pattern* and *compulsive reassurance-seeking* are not the primary features of GAD. *Body dysmorphic disorder* - BDD involves a preoccupation with a perceived defect in one's *physical appearance*, which is distinct from being concerned about a bodily function product like stool. - The focus is on a part of the body that feels "ugly" or "disfigured," not on the internal state or product of a bodily process. *Illness anxiety disorder* - This disorder involves a *preoccupation with having or acquiring a serious illness*, despite minimal or no somatic symptoms, and is often characterized by health-related anxiety. - While there is health anxiety, the patient's primary concern is specifically about the *appearance of his stool* rather than the fear of a serious underlying disease. *Major depressive disorder* - This is characterized by *persistent sadness, loss of interest/pleasure, and other depressive symptoms* for at least two weeks. - While depression can involve ruminative thoughts, the specific obsessive-compulsive pattern described, focused on a non-depressive theme, is not typical of MDD as the primary diagnosis.
Explanation: ***Buspirone*** - This patient's symptoms of **generalized anxiety** (excessive worry, difficulty sleeping, irritability, on edge for 6 months) without panic attacks or phobias, and a history of depression, make buspirone a suitable choice. - **Buspirone** is a non-benzodiazepine anxiolytic that is effective for **generalized anxiety disorder** and has a lower risk of dependence compared to benzodiazepines, making it a good option for chronic use. *Diazepam* - **Diazepam** is a benzodiazepine, primarily used for acute anxiety or short-term management due to its **rapid onset of action**. - Its potential for **dependence and withdrawal symptoms** makes it less ideal for chronic anxiety management, especially in a patient with a predisposition to depression and requesting "sleeping pills". *Desensitization therapy* - **Desensitization therapy** (a form of exposure therapy) is primarily used for **phobias** and **post-traumatic stress disorder**, where specific triggers are identified. - The patient's presentation of generalized, pervasive worry, rather than a fear of specific situations, suggests this would not be the most effective initial treatment. *Relaxation training* - While beneficial as an adjunct, **relaxation training** alone is generally not sufficient as the **most effective monotherapy** for generalized anxiety disorder, especially given the severity and duration of the patient's symptoms. - The patient has already tried **sleep hygiene practices**, indicating that behavioral interventions alone might not be enough to manage her anxiety. *Bupropion* - **Bupropion** is an antidepressant primarily used for **major depressive disorder** and **smoking cessation**. - It is generally **not efficacious for anxiety disorders** and can sometimes exacerbate anxiety due to its stimulating effects.
Explanation: ***Genito-Pelvic Pain/Penetration Disorder*** - This diagnosis is strongly supported by the patient's complaints of **discomfort** and **pelvic floor muscle tightening** during attempted vaginal penetration, leading to an aborted speculum exam. - The long duration of **infertility** despite regular intercourse and the husband's erectile difficulties also point towards a combined issue affecting sexual function and penetration. *Endometriosis* - While endometriosis can cause **dyspareunia** (painful intercourse), it primarily involves **pelvic pain** that is often cyclical and not solely triggered by penetration attempts with associated muscle tightening. - The absence of other classic symptoms like severe dysmenorrhea or chronic pelvic pain makes this less likely. *Painful bladder syndrome* - This condition is characterized by chronic **bladder pain** accompanied by urinary urgency and frequency, which are not mentioned in this patient's presentation. - The pain is typically localized to the bladder and not primarily experienced as muscle tightening during penetration. *Vulvodynia* - Vulvodynia involves chronic **vulvar pain** without an identifiable cause, which can be provoked or unprovoked. - While it can cause pain during attempted penetration, the strong emphasis on **pelvic floor muscle tightening** and the psychological component (body dysmorphic disorder) aligns more closely with genito-pelvic pain/penetration disorder. *Vulvovaginitis* - This is an **inflammation of the vulva and vagina**, typically caused by infection or irritation, leading to symptoms like **redness, itching, burning, and discharge**. - The patient's presentation specifically notes a normal appearing vulva without redness or vaginal discharge, making vulvovaginitis unlikely.
Explanation: ***Avoidant*** - This patient exhibits symptoms consistent with **agoraphobia**, which is an **anxiety disorder** characterized by fear of situations where escape might be difficult or help unavailable, often leading to social isolation. - **Avoidant Personality Disorder** has the strongest genetic association with anxiety disorders, particularly **social anxiety disorder and agoraphobia**, sharing common genetic vulnerability factors related to fear of negative evaluation and social avoidance. - Studies demonstrate significant genetic overlap between avoidant personality disorder and anxiety spectrum disorders, making this the most likely genetically associated personality disorder. *Schizotypal* - **Schizotypal Personality Disorder** is genetically linked to the **schizophrenia spectrum** (not anxiety disorders), characterized by cognitive-perceptual distortions, eccentric behavior, and social deficits. - While schizotypal patients may avoid social situations, this is due to odd thinking and discomfort with close relationships, not anxiety about specific situations like crowds or public transportation. *Dependent* - **Dependent Personality Disorder** is characterized by an excessive need to be taken care of, leading to **submissive and clinging behavior**, and fears of separation. - This patient's withdrawal is due to fear of public places, not a reliance on others or fear of abandonment. *Antisocial* - **Antisocial Personality Disorder** involves a pervasive pattern of **disregard for and violation of the rights of others**, often presenting as deceitful and impulsive behavior. - The patient's symptoms are rooted in anxiety and social avoidance rather than a lack of empathy or antisocial behavior. *Paranoid* - **Paranoid Personality Disorder** is characterized by a pervasive **distrust and suspiciousness of others**, interpreting their motives as malevolent. - The patient's withdrawal stems from fear of specific situations (crowds, public transport) rather than paranoid ideation or general suspicion of people's intentions. *Histrionic* - **Histrionic Personality Disorder** is marked by **excessive emotionality and attention-seeking behavior**, often displaying dramatic and superficial interactions. - The patient's isolation and fear of public spaces are directly opposite to the attention-seeking nature of histrionic traits.
Explanation: ***Diazepam*** - This patient presents with classic **benzodiazepine withdrawal syndrome**: anxiety, tremors, sweating, tachycardia, tachypnea, and progressive confusion after being unable to take his home benzodiazepines (clonazepam and lorazepam). - Benzodiazepine withdrawal is a **medical emergency** that can progress to seizures, delirium, and death if untreated. - **Diazepam** is the preferred treatment due to its **long half-life**, which provides smooth, sustained benzodiazepine receptor activity and prevents withdrawal progression. - The autonomic instability (elevated pulse and respiratory rate) and neurological symptoms (tremors, confusion) require immediate benzodiazepine administration, not just supportive care. *Supportive therapy and monitoring* - While monitoring is important, **supportive care alone is inadequate** for benzodiazepine withdrawal with autonomic instability and confusion. - Untreated benzodiazepine withdrawal can rapidly progress to **seizures, severe delirium, and cardiovascular collapse**. - The objective signs (tachycardia, tremors, sweating, confusion) indicate physiological withdrawal, not simply anxiety or drug-seeking behavior. - Active treatment with benzodiazepines is the **standard of care** to prevent life-threatening complications. *Sodium bicarbonate* - Sodium bicarbonate treats **metabolic acidosis** or specific overdoses (e.g., tricyclic antidepressants, aspirin). - There is no indication of acidosis or TCA toxicity in this presentation; the patient has withdrawal symptoms, not overdose. *Flumazenil* - Flumazenil is a benzodiazepine antagonist that **reverses benzodiazepine effects** in acute overdose. - It is **absolutely contraindicated** in patients with chronic benzodiazepine use or dependence, as it can precipitate **severe withdrawal, seizures, and status epilepticus**. - This patient needs benzodiazepine administration, not reversal. *Midazolam* - While midazolam is a benzodiazepine that could treat withdrawal acutely, its **short half-life** makes it less ideal for managing withdrawal syndrome. - **Diazepam or chlordiazepoxide** (long-acting agents) are preferred for withdrawal management as they provide sustained coverage and smoother tapering. - Midazolam would require frequent redosing and carries higher risk of rebound withdrawal.
Explanation: ***Sleep restriction*** - The patient's symptoms of difficulty falling asleep, frequent awakenings, and early morning awakening, particularly in an older adult, are classic signs of **insomnia**. Sleep restriction therapy is a behavioral intervention that helps consolidate sleep by initially limiting the time spent in bed to the actual amount of time slept. - This method aims to increase **sleep drive** and improve **sleep efficiency** by creating mild sleep deprivation, making it easier to fall asleep and stay asleep. *Bilevel positive airway pressure (BiPAP)* - **BiPAP** is a treatment for **sleep apnea**, a condition characterized by snoring, witnessed apneas, and daytime somnolence, none of which are reported by the patient or her husband. - The patient's husband explicitly states she does not snore, and her BMI is normal, making sleep apnea less likely. *Paradoxical intention* - **Paradoxical intention** is a cognitive behavioral therapy technique where an individual is instructed to *try* to stay awake. It is primarily used for **performance anxiety** related to sleep onset and might be considered as part of a broader CBT-I program after initiating core behavioral strategies. - While it can be helpful for some aspects of insomnia, it is typically not the **first-line behavioral intervention** for general insomnia symptoms as described. *Reassurance* - While reassurance can be part of patient education, simply reassuring the patient without offering specific interventions does not address the underlying **insomnia disorder** or provide tools for improvement. - The patient has been experiencing these symptoms for several years and is seeking active management, indicating that reassurance alone is insufficient. *Flurazepam* - **Flurazepam** is a **long-acting benzodiazepine** with a high risk of **daytime sedation**, **cognitive impairment**, and **falls** in elderly patients. - Due to its long half-life and potential for adverse effects, especially in older adults, it is generally **not recommended as a first-line treatment** for chronic insomnia in this demographic; behavioral therapies are preferred initially.
Generalized anxiety disorder
Practice Questions
Panic disorder
Practice Questions
Specific phobias
Practice Questions
Social anxiety disorder
Practice Questions
Separation anxiety disorder
Practice Questions
Agoraphobia
Practice Questions
Neurobiological basis of anxiety
Practice Questions
Cognitive-behavioral therapy for anxiety
Practice Questions
Pharmacotherapy for anxiety disorders
Practice Questions
Anxiety in medical conditions
Practice Questions
Anxiety in children and adolescents
Practice Questions
Alternative treatments for anxiety
Practice Questions
Anxiety disorder differential diagnosis
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free